apomorphine has been researched along with Anochlesia in 299 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 175 (58.53) | 18.7374 |
| 1990's | 64 (21.40) | 18.2507 |
| 2000's | 29 (9.70) | 29.6817 |
| 2010's | 29 (9.70) | 24.3611 |
| 2020's | 2 (0.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kadiri, SK; Karkar, VV; Pal Roy, S; Rao Konijeti, S | 1 |
| Balenovic, I; Blagaic, AB; Cilic, M; Drmic, D; Filipcic, I; Ilic, S; Kokot, A; Seiwerth, S; Sikiric, P; Strbe, S; Tvrdeic, A; Vukojevic, J; Zemba Cilic, A; Zemba, M; Zoricic, Z | 1 |
| Adjei, S; Amoateng, P; Karikari, TK; Kukuia, KKE; Nyarko, AK; Osei-Safo, D | 1 |
| Adjei, S; Amoateng, P; Bekoe, EO; Karikari, TK; Kombian, SB; Kukuia, KKE; Osei-Safo, D | 1 |
| Aderibigbe, AO; Ajayi, AM; Ben-Azu, B; Iwalewa, EO; Omogbiya, IA | 1 |
| Antonio, CB; Betti, AH; da Rocha Pitta, I; do Rego, JC; do Rego, JL; Herzfeldt, V; Pitta, MGDR; Rates, SMK; Vaudry, D | 1 |
| Battaglia, G; Bucci, D; Consolazione, M; Lionetto, L; Maccari, S; Mairesse, J; Marrocco, J; Morley-Fletcher, S; Nicoletti, F; Ravasi, L; Simmaco, M | 1 |
| Allikalt, A; Dzirkale, Z; Jekabsons, K; Klusa, V; Mazina, O; Muceniece, R; Rinken, A; Rumaks, J; Svirskis, S | 1 |
| Czarnecka, A; Kamińska, K; Konieczny, J; Lenda, T; Lorenc-Koci, E | 1 |
| Abdu-Aguye, I; Hussaini, IM; Magaji, MG; Magaji, RA; Mohammed, M; Musa, AM | 1 |
| Kilic, FS; Kulluk, D; Musmul, A | 1 |
| Abdulla, A; Kaklotar, D; Muthu, MS; Pandey, BL; Rajesh, CV; Sahu, AK; Singh, S | 1 |
| Ablordeppey, SY; Bricker, B; Lamango, NS; Peprah, K; Roth, BL; Sampson, D; Setola, V; Zhu, XY | 1 |
| Masui, A; Minamimoto, S; Mizobe, Y; Mizuguchi, Y; Ochiai, M; Ohno, Y; Shimizu, S; Tamura, M; Tatara, A | 1 |
| Bienkowski, P; Kolaczkowski, M; Marcinkowska, M; Mierzejewski, P; Pawlowski, M; Samochowiec, J; Wesolowska, A | 1 |
| Balsara, JJ; Gaonkar, RK; Malekar, AR | 1 |
| Carey, RJ; Carrera, MP; Dias, FRC; Oliveira, LR; Santos, BG; Silva, JLL | 1 |
| Blobaum, AL; Bubser, M; Conn, PJ; Daniels, JS; Engers, DW; Hopkins, CR; Javitch, JA; Jones, CK; Lin, X; Lindsley, CW; Loch, MT; Niswender, CM; Rodriguez, AL; Thompson Gray, A | 1 |
| Comery, TA; Graf, R; Grauer, SM; Huselton, C; Liu, Z; Logue, SF; Marquis, KL; Navarra, R; Rosenzweig-Lipson, S; Stack, G; Sung, A | 1 |
| Belopolskaya, MV; Dugina, JL; Epstein, OI; Kheyfets, IA; Sergeeva, SA; Voronina, TA | 1 |
| Becker, A; Berek, I; Grecksch, G; Härtl, A; Höllt, V; Schröder, H | 1 |
| Mishra, A; Muthu, MS; Rawat, MK; Singh, S | 1 |
| Brandon, NJ; Brennan, J; Charych, E; Comery, TA; Egerland, U; Graf, R; Grauer, SM; Hage, T; Jiang, L; Kelley, C; Kelly, MP; Langen, B; Liu, F; Logue, S; Malamas, M; Marquis, KL; Navarra, RL; Pulito, VL | 1 |
| de Araújo, FY; de Moraes, MO; de Oliveira, GV; de Sousa, FC; Leal, LK; Macêdo, DS; Moura, BA; Silva, MI; Vasconcelos, SM; Viana, GS | 1 |
| Amalric, M; Flor, PJ; Greco, B; Lopez, S; van der Putten, H | 1 |
| Ardayfio, PA; Carlezon, WA; Choi, YK; Hwang, DY; Kim, KS; Leung, A; Moran-Gates, T; Park, J; Tarazi, FI | 1 |
| Harada, K; Katsuoka, M; Kondo, Y; Matsuoka, N; Mihara, T; Ni, K; Shobo, M; Yamada, H; Yamamoto, N | 1 |
| Bernardi, MM; Flório, JC; Kirsten, TB; Palermo-Neto, J; Taricano, M | 1 |
| Calas, AG; Goursaud, S; Hermans, E; Jeanjean, AP; Koener, B; Maloteaux, JM; Van De Stadt, M | 1 |
| Andreatini, R; Chioca, LR; Correia, D; Pereira, M; Pizzolatti, MG; Santos, AR; Siba, IP; Vital, MA | 1 |
| Bilge, U; Erol, K | 1 |
| Akhtar, M; Khanam, R; Mahmood, D; Pillai, KK | 1 |
| Afzal, M; Ahmed, S; Ahmed, Z; Anwar, F; Ashraf, MS; Gupta, G; Kazmi, I; Khusroo, MJ; Mujeeb, M; Nazeer, K; Rahman, M; Saleem, S | 1 |
| Atack, J; Cik, M; De Bruyn, M; Hendrickx, H; Langlois, X; Lavreysen, H; Macdonald, G; Megens, A; Peeters, L; te Riele, P; Vermeire, J; Wouters, R | 1 |
| Dabole, B; Dawe, A; De Waard, M; Dimo, T; Djomeni Dzeufiet, PD; Ngo Bum, E; Okomolo Moto, FC; Sidiki, N; Sotoing Taïwe, G; Talla, E; Temkou Ngoupaye, G | 1 |
| Bini, V; Bortolato, M; Devoto, P; Frau, R; Pillolla, G; Tambaro, S | 1 |
| Antonio, CB; Barreiro, EJ; Betti, AH; Fraga, CA; Neves, G; Noël, F; Pranke, MA; Rates, SM | 1 |
| Aristakesian, EA; Kuzik, VV; Oganesian, GA; Romanova, IV; Vataev, SI | 1 |
| Horikomi, K; Karasawa, J; Takagi, K; Takahashi, S | 1 |
| Bjartmar, C; Trapp, BD | 1 |
| Amalric, M; Baunez, C; Darbaky, Y; Forni, C | 1 |
| JANSSEN, PA; NIEMEGEERS, CJ; SCHELLEKENS, KH | 1 |
| Ablordeppey, SY; Li, S; Lyles-Eggleston, M; Sikazwe, DM | 1 |
| Bardin, L; Barret-Grévoz, C; Depoortère, R; Kleven, MS; Newman-Tancredi, A | 1 |
| Artaiz, I; Castro, E; Del Olmo, E; Innerárity, A; Labeaga, L; Orjales, A; Pazos, A; Zazpe, A | 1 |
| Akhtar, M; Ali, A; Pillai, KK; Uma Devi, P; Vohora, D | 1 |
| Assié, MB; Consul-Denjean, N; Dominguez, H; Newman-Tancredi, A | 1 |
| Ashby, CR; Barrett, JE; Brennan, JA; Comery, TA; Dawson, LA; Grauer, SM; Harrison, BL; Logue, SF; Marquis, KL; Meltzer, HY; Nguyen, HQ; Piesla, MJ; Rosenzweig-Lipson, S; Sabb, AL; Stack, G | 1 |
| Giridharagopalan, S; Hamamoto, DT; Simone, DA | 1 |
| Agai-Csongor, E; Bielik, A; Domány, G; Galambos, J; Gémesi, L; Greiner, I; Gyertyán, I; Ignácz-Szendrei, G; Keseru, GM; Kiss, B; Laszlovszky, I; Laszy, J; Magdó, I; Nógrádi, K; Sághy, K; Schmidt, E; Vágó, I; Zájer-Balázs, M | 1 |
| Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM | 1 |
| Freichel, C; Künnecke, B; Maco, M; Moreau, JL; Nordquist, RE; Riemer, C; Risterucci, C; Spooren, W; von Kienlin, M | 1 |
| Akanmu, MA; Owolabi, AR; Ukponmwan, OE | 1 |
| Anouans, ZE; Georgiev, VP; Klousha, VE; Markovska, VL; Mountsinietse, RK; Petkov, VD; Svirskis, SV | 1 |
| Zetler, G | 1 |
| Balsara, JJ; Chandorkar, AG; Jadhav, JH | 2 |
| German, DC; McMillen, BA; Sanghere, MK; Shore, PA; Warnack, W | 1 |
| Bekemeier, H; Krause, E | 1 |
| Chiu, S; Mishra, RK | 1 |
| Gale, K; Stoff, DM | 1 |
| Chiu, S; Mishra, RK; Paulose, CS | 1 |
| Fujiwara, M; Kasahara, A; Kojima, H; Sakurai, T; Ueki, S; Watanabe, S; Yamasaki, T | 1 |
| Havemann, U | 1 |
| Langwiński, R; Malec, D | 1 |
| Barghon, R; Colboc, O; Costentin, J; Protais, P | 1 |
| Chen, PC; Matsuda, H; Nishimori, T; Shibuya, T | 1 |
| Florvall, L; Ogren, SO | 1 |
| Worms, P | 1 |
| Chase, TN; Cohen, SL; Knight, M; Tamminga, CA | 1 |
| Boff, E; Cook, L; Davidson, AB; MacNeil, DA; Wenger, J | 1 |
| Bianchetti, G; Lloyd, KG; Morselli, PL; Worms, P | 1 |
| Creese, I; Hamblin, MW | 1 |
| Bucher, B; Dorme, N; Jalfre, M; Mocquet, G; Porsolt, RD | 1 |
| Mattiace, LA; McMillen, BA | 1 |
| Fuxe, K; Köhler, C; Ogren, SO | 1 |
| Angeby, K; Florvall, L; Hall, H; Köhler, C; Lindbom, LO; Magnusson, O; Ogren, SO | 1 |
| Balsara, JJ; Chandorkar, AG; Gada, VP; Nandal, NV | 1 |
| Dunn, AJ; Guild, AL | 1 |
| Allikmets, LKh; Maĭmets, MO; Nurk, AM; Riago, LK; Vasar, EE | 1 |
| Bartholini, G; Depoortere, H; Durand, A; Lloyd, KG; Morselli, PL; Worms, P | 1 |
| Miller, JC | 1 |
| Ossowska, K; Smiałowska, M; Wolfarth, S | 1 |
| Klemm, WR | 3 |
| Balsara, JJ; Burte, NP; Chandorkar, AG; Jadhav, JH; Nandal, NV | 1 |
| Hong, GX; Jin, GZ; Wang, XL | 1 |
| Fleminger, S; Hall, MD; Jenner, P; Marsden, CD; Murugaiah, K; Theodorou, A | 1 |
| Matvienko, OA; Nurk, AM; Zharkovskiĭ, AM | 1 |
| Costall, B; Kelly, ME; Naylor, RJ | 1 |
| Crider, AM; Fahn, S; Hassan, MN; Hemdi, TF | 1 |
| Gallitto, G; Giammona, G; Nicoletti, F; Patti, F; Rampello, L; Reggio, A | 1 |
| Bernardini, R; Clementi, G; De Simone, D; Nicoletti, F; Patti, F; Prato, A; Scapagnini, U | 1 |
| Balsara, JJ; Bapat, TR; Chandorkar, AG; Gada, VP | 1 |
| Dorow, R; Wachtel, H | 1 |
| Harasiewicz, A; Kolasiewicz, W; Melzacka, M; Wolfarth, S | 1 |
| Lloyd, KG; Worms, P | 2 |
| Banning, JW; Beal, JL; Patil, PN; Uretsky, NJ | 1 |
| Brown, J; Handley, SL | 1 |
| Shalaby, IA; Spear, LP | 1 |
| Bordash, GD; Corso, P; Wallnau, LB | 1 |
| Mintz, M; Myslobodsky, MS | 1 |
| Allikmets, LH; Nurk, AM; Rägo, LK; Zarkovsky, AM | 1 |
| Kulkarni, SK; Verma, A | 1 |
| Crocker, AD; Double, KL; Lee, CY | 1 |
| Guanowsky, V; Howard, HR; Lebel, LA; Lowe, JA; McLean, S; Schmidt, AW; Schulz, DW; Seeger, TF; Seymour, PA; Zorn, SH | 1 |
| Palermo-Neto, J; Sandoval, MR | 1 |
| Minematsu, N | 1 |
| Hirose, T; Kikuchi, T; Miwa, T; Morita, S; Oshiro, Y; Tottori, K; Uwahodo, Y | 1 |
| Consolo, S; Costi, P; Kleinrok, Z; Kolasa, K; Zecca, L | 1 |
| Conway, PC; Corbett, R; Dunn, RW; Hartman, H; Helsley, GC; Kerman, LL; Strupczewski, JT; Woods, AT | 1 |
| Burzynski, SR; Chodkowska, A; Feldo, M; Juszkiewicz, M; Kleinrok, Z; Majewska, B | 1 |
| Archer, T; Ogren, SO | 1 |
| Malick, JB; Migler, BM; Warawa, EJ | 1 |
| Reis, M; Rigon, AR; Takahashi, RN | 1 |
| Araki, Y; Furuno, K; Gomita, Y; Suemaru, K | 1 |
| Lipska, BK; Weinberger, DR | 1 |
| Cooper, BR; Navas, F; Norman, MH; Rigdon, GC | 1 |
| Amabeoku, GJ | 1 |
| Bubser, M; Schmidt, WJ | 1 |
| Carruba, MO; da Prada, M; Imhof, R; Nisoli, E; Scherschlicht, R; Tonello, C | 1 |
| Kisara, K; Ohizumi, Y; Oshima, Y; Subarnas, A; Tadano, T | 1 |
| Angeby-Möller, K; Hall, H; Ogren, SO; Widman, M | 1 |
| Conceição, IM; Frussa-Filho, R | 1 |
| Fisher, H; Johnson, SK; Wagner, GC | 1 |
| Chase, TN; Kapitzoglou-Logothetis, V; Marin, C; Parashos, SA; Peppe, A | 1 |
| Braun, AR; Jaskiw, GE; Lipska, BK; Weinberger, DR | 1 |
| Bartoszyk, GD; Harting, J; Minck, KO | 1 |
| Ewing, FE; Furman, JS; Howard, HR; Jackson, E; Johnson, C; Lowe, JA; Maloney, PR; Morrone, J; Newman, ME; Robinson, GL; Schmidt, AW; Seeger, TF; Seymour, PA; Zorn, SH | 1 |
| Anglada, L; Bolós, J; Burgarolas, C; Castelló, JM; Gubert, S; Ortiz, JA; Planas, JM; Sacristán, A | 1 |
| Corbett, R; Kafka, SH | 1 |
| Dixon, AK; Gull, P; Hoyer, D; Jaton, AL; Markstein, R; McAllister, K; Rüdeberg, C; Urwyler, S | 1 |
| Baĭchurina, AZ; Garaev, RS; Semina, II | 1 |
| Hirano, H; Kaneyuki, H; Kawano, M; Mizuki, Y; Suetsugi, M; Usami, K; Ushijima, I; Yamada, M | 1 |
| Braun, AR; Laruelle, M; Mouradian, MM | 1 |
| Chopde, CT; Mandhane, SN; Muthal, AV | 1 |
| Wiśniewski, K; Zalewska, A | 1 |
| Berendsen, HH; Broekkamp, CL; Pinder, RM | 1 |
| Kikuchi, T; Kurahashi, N; Nishi, T; Oshiro, Y; Sato, S; Tanaka, T; Tottori, K; Uwahodo, Y | 1 |
| Costa-Campos, L; Elisabetsky, E; Lara, DR; Nunes, DS | 1 |
| Davidkova, G; Morabito, M; Weiss, B; Zhang, SP; Zhou, LW | 1 |
| Chen, LJ; Jin, GZ; Pang, DW; Xi, Y; Zhou, QT | 1 |
| Kulkarni, SK; Ninan, I | 1 |
| Chopra, K; Kulkarni, SK; Raghavendra, V | 1 |
| Horikomi, K; Iizuka, K; Mita, N; Miwa, T; Nagase, H; Sakai, K; Sonehara, K; Takagi, K; Takahashi, S | 1 |
| Brust, P; Gupta, CN; Parimoo, P; Raghavan, SA; Rangisetty, JB; Sridhar, N; Srinivas, P; Subramanian, AR; Veeranjaneyulu, A | 1 |
| Asmakova, LS; Bondarenko, NA; Gudasheva, TA; Kalinina, TS; Ostrovskaya, RU; Seredenin, SB; Voronina, TA; Zaitseva, NI | 1 |
| Geurts, M; Hermans, E; Maloteaux, JM | 1 |
| Boules, M; Cusack, B; Fauq, A; McCormick, DJ; Richelson, E; Tyler, BM | 1 |
| Fletcher, PJ; Kapur, S; Sills, TL; Wadenberg, MG | 1 |
| Balsara, JJ; Moorthy, NS | 1 |
| Andreatini, R; Beijamini, V; Joca, SR; Skalisz, LL; Vital, MA | 1 |
| Antkiewicz-Michaluk, L; Michaluk, J; Papla, I; Romańska, I; Vetulani, J | 1 |
| Baik, JH; Borrelli, E; Dierich, A; LeMeur, M; Piazza, PV; Picetti, R; Rougé-Pont, F; Usiello, A | 1 |
| Baldessarini, RJ; Bradley, MO; Campbell, A; Flood, JG; Hemamalini, S; Kula, NS; Shashoua, VE; Swindell, CS; Webb, NL | 1 |
| Chen, LJ; Dong, ZJ; Jin, GZ; Yu, LP; Zhou, QT | 1 |
| Cervo, L; De Deurwaerdère, P; Spampinato, U; Stinus, L | 1 |
| Fujimura, M; Hashimoto, K; Kimura, K; Kuriyama, M; Morimoto, T; Takehara, S; Tanaka, H; Yamagami, K; Yasumatsu, H | 1 |
| Chopde, CT; Deshpande, LS; Khisti, RT | 1 |
| Erzin-Waters, C; Muller, P; Seeman, P | 1 |
| Colombo, M; Moragues, J; Prieto, J; Roberts, DJ; Salazar, W; Spickett, RG; Vega, A | 1 |
| Di Chiara, G; Gessa, GL; Longoni, R; Mulas, A; Porceddu, ML; Vargiu, L | 1 |
| Clow, A; Elliott, PN; Jenner, P; Marsden, CD; Reavill, C | 1 |
| Costall, B; Naylor, RJ | 2 |
| Arimoto, M; Kasahara, A; Kojima, H; Sakurai, T; Sato, M; Ueno, K; Yamasaki, T | 1 |
| Irie, A; Masuda, Y; Nagai, Y; Oka, M; Uno, H | 1 |
| Maeno, H; Sano, K; Usuda, S | 1 |
| Kamei, C; Oka, M; Shimizu, M; Yamada, K; Yoshida, K | 1 |
| Bruinvels, J; Moleman, P; Versluis, DJ | 1 |
| Gianutsos, G; Lal, H; Puri, SK | 1 |
| Da Prada, M; Haefely, W; Pieri, L; Pieri, M; Schaffner, R | 1 |
| Golembiowska, K; Mogilnicka, E; Scheel-Krüger, J | 1 |
| Chrétien, M; Izumi, K; Motomatsu, T | 1 |
| Jenner, PG; Marsden, CD; Pycock, CJ | 1 |
| Elliott, PN; Huizing, G; Jenner, P; Marsden, CD; Miller, R | 1 |
| Czlonkowski, A; Herz, A; Höllt, V | 1 |
| Pycock, C | 1 |
| Honda, F; Kato, R; Noguchi, H; Satoh, H; Satoh, Y; Shimomura, K; Uchida, S | 1 |
| Kim, C; Van Loon, GR | 1 |
| Carchedi, F; Casacchia, M; Cerbo, R; Meco, G | 1 |
| Barbeau, A; Belanger, F; Jolicoeur, FB; Rondeau, DB | 1 |
| De Montis, GM; Olianas, MC; Scheel-Krüger, J; Serra, G; Tagliamonte, A | 1 |
| Hikasa, N; Otsuki, S; Sato, M; Tomoda, T | 1 |
| Chen, PC | 1 |
| Altshuler, HL; Epstein, PN | 1 |
| Muller, P; Seeman, P | 1 |
| Angeby, T; Haglund, L; Köhler, C; Ogren, SO | 1 |
| Carter, CJ; Pycock, CJ | 1 |
| Allikmets, LKh; Otter, MIa; Zharkovskiĭ, AM | 1 |
| Delini-Stula, AA; Waldmeier, PC | 1 |
| Kuschinsky, K; Langer, J; Seeber, U; Sontag, KH | 1 |
| Melzacka, M; Rurak, A; Smiałowski, A; Vetulani, J | 1 |
| Boeck, V; Danneskiold-Samsoe, P; Nielsen, IM; Pedersen, V; Svendsen, O | 1 |
| Boeck, V; Christensen, AV; Danneskiold-Samsoe, P; Hyttel, J; Langeland, J; Nielsen, IM; Pedersen, V; Svendsen, O | 1 |
| Ishida, R; Ito, K; Kowa, Y; Nurimoto, S; Shintomi, K; Yamamura, M | 1 |
| Cervantes, P; Guyda, H; Lal, S; Smith, F | 1 |
| Fujiwara, M; Inoue, K; Ueki, S | 1 |
| Bidzinski, A; Gajewska, S; Hauptman, M; Kostowski, W | 1 |
| Yamahara, J | 1 |
| Herr, F; Voith, K | 1 |
| Nahorski, SR | 1 |
| Ahtee, L | 1 |
| Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S | 1 |
| Janssen, PA; Lenaerts, FM; Niemegeers, CJ; Schellekens, KH; Wauquier, A | 1 |
| Axton, MS; Moore, NA; Risius, FC; Tye, NC | 1 |
| Clementi, G; Drago, F; Fiore, CE; Grassi, M; Prato, A; Valerio, C | 1 |
| Dunn, RW; Errico, CL; Hrib, NJ; Huger, FP; Jurcak, JG | 1 |
| Cunha, JM; Rodrigues, JA; Zuardi, AW | 1 |
| Behrens, S; De Vry, J; Gattaz, WF; Häfner, H | 1 |
| Li, BH; Li, Q | 1 |
| Di Scala, G; Kempf, E; Lannes, B; Micheletti, G; Warter, JM | 1 |
| Coward, DM; Dixon, AK; Enz, A; Karobath, M; Shearman, G; Urwyler, S; White, TG | 1 |
| Elazar, Z; Ganchrow, D; Korczyn, AD; Paz, M; Paz, Z; Rabinowitz, R | 1 |
| Abe, E; Fujiwara, H; Itoh, T; Kohori, I; Masuda, Y; Murai, S; Saito, H | 1 |
| Georgieva, JV | 1 |
| Kádár, T; Schally, AV; Telegdy, G | 1 |
| Balsara, JJ; Bapat, TR; Bende, MM; Chandorkar, AG | 1 |
| de Souza-Spinosa, H; Górniak, SL; Palermo-Neto, J | 1 |
| Casas, M; Ferré, S; Guix, T; Jane, F; Prat, G | 1 |
| Flório, JC; Palermo-Neto, J | 1 |
| Ackerman, M; Artman, LD; Asin, KE; Bednarz, L; Johnson, MC; Kebabian, JW; Kerkman, DJ; MacKenzie, RG; Montana, W; Stampfli, H | 1 |
| Kamburova, T; Kehayov, R; Markovska, V | 1 |
| Ishida, R; Kinoshita, K; Maeda, K; Nakagawa, H; Yamamura, M | 1 |
| Cascio, G; Fregnan, G; Manghisi, E | 1 |
| Fico, TA; Spoerlein, MT; Vanderwende, C; Wilmot, CA | 1 |
| Fukuda, T; Morimoto, T; Morimoto, Y; Murakami, S; Setoguchi, M; Shoji, H; Tahara, T | 1 |
| Getova, D; Markovska, V | 1 |
| Florvall, L; Hall, H; Köhler, C; Magnusson, O; Ogren, SO | 1 |
| Gerhards, HJ; Henning, R; Lattrell, R; Leven, M | 1 |
| Fujiwara, M; Kamiya, H; Ono, N; Saito, R | 1 |
| Eison, MS; Gross, SM; New, JS; New, KB; Riblet, LA; Schlemmer, RF; Taylor, DP; Temple, DL; Yevich, JP | 1 |
| Barnett, A; Berger, JG; Chipkin, RE; Coffin, VL; Iorio, LC; McQuade, RD | 1 |
| al-Rashood, KA; Alhaider, AA; el-Obeid, HA; Ginawi, OT; Madani, AA; Mustafa, AA | 1 |
| Arnt, J | 1 |
| Hall, H; Köhler, C; Magnusson, O; Ogren, SO; Sjöstrand, SE | 1 |
| Baldessarini, RJ; Campbell, A; Neumeyer, JL; Teicher, MH | 1 |
| Campbell, W; Clark, MS; Mitchell, PJ; Needham, PL; Semple, JM | 1 |
| Chowdhury, BK; Iriah, J; Ogbeide, ON; Orkor, D; Sokomba, E; Wambebe, C | 1 |
| Brown, F; Campbell, W; Clark, MS; Graves, DS; Hadley, MS; Hatcher, J; Mitchell, P; Needham, P; Riley, G; Semple, J | 1 |
| Friedhoff, AJ; Goldstein, M; Kuga, S; Meller, E | 1 |
| Block, H; Klemm, WR | 1 |
| Kuschinsky, K; Nowak, K; Welsch-Kunze, S | 1 |
| Ancans, JE; Georgiev, VP; Getova, DP; Kambourova, TS; Klusha, VE; Mutsenietse, RK; Oppitz, MZh; Petkov, VD; Svirskis, SV | 1 |
| Usuda, S | 1 |
| Avdelidis, D; Spyraki, C | 1 |
| Amir, S | 1 |
| Morato, GS; Takahashi, RN | 1 |
| Vamvakidès, A | 2 |
| Besson, MJ; Danguir, J; Girault, JA; Glowinski, J; Savaki, HE; Spampinato, U | 1 |
| Aizenstein, ML; de-Lucia, R; Scavone, C; Steinschreiber, S | 1 |
| Brus, R; Gmerczyński, T; Makowska, B; Stanosek, B | 1 |
| Kikuchi, T; Maeda-Hagiwara, M; Uramoto, H; Watanabe, H | 1 |
| Beliakov, AV; Matvienko, OA; Neduva, AA; Zharkovskiĭ, AM | 1 |
| Randall, PK; Yurek, DM | 1 |
| Hruska, RE | 1 |
| Bürki, HR | 1 |
| Handley, SL; Sayers, AC | 1 |
| Bourat, G; Ducrot, R; Fournel, J; Garret, C; Julou, L | 1 |
| Johnson, AM; Loew, DM; Vigouret, JM | 1 |
| Ahtee, L; Kääriäinen, I | 1 |
| Ungerstedt, U | 1 |
| Weissman, A | 1 |
| Dresse, A; Janssen, PA; Lenaerts, FM; Niemegeers, CJ; Pinchard, A; Schaper, WK; Schellekens, KH; van Nueten, JM; Verbruggen, FJ | 1 |
| Büch, O; Delini-Stula, A; Eigenmann, R; Levin, P; Theobald, W | 1 |
| Andén, NE; Bédard, P | 1 |
| Janssen, PA; Niemegeers, CJ | 1 |
| Honma, T; Inaba, S; Kitagawa, S; Ono, K; Sasajima, K; Yamamoto, H | 1 |
| Lauener, H; Stille, G | 1 |
| Di Chiara, G; Gessa, GL; Perez-Cruet, J; Sasame, HA; Tagliamonte, A; Tagliamonte, P | 1 |
| Hornykiewicz, O; Kuschinsky, K | 2 |
| Belendiuk, G; Lal, S; Missala, K; Sourkes, TL | 1 |
| Cashin, CH; Sutton, S | 1 |
| Asper, H; Baggiolini, M; Burki, HR; Lauener, H; Ruch, W; Stille, G | 1 |
| Grabowska, M | 1 |
| Thörner, R; Zetler, G | 1 |
| Gouret, C; Raynaud, G | 1 |
| Papeschi, R; Randrup, A | 1 |
| Fjalland, B; Moller Nielsen, I; Nymark, M; Pedersen, V | 1 |
| Baran, L; Maj, J; Sarnek, J; Sowińska, H | 1 |
| Loh, HH; Tseng, LF | 1 |
| Ogasawara, T; Ogawa, N; Ueki, S | 1 |
| Dlabac, A; Kazdová, E; Metysová, J | 1 |
| Boissier, JR; Etevenon, P; Piarroux, MC; Simon, P | 1 |
| Metys, J; Metysová, J; Protiva, M; Sindelár, K | 1 |
| Hester, JB; Keasling, HH; Rudzik, AD; Veldkamp, W | 1 |
| Arnold, OH; Collard, J; Deniker, P; Ginestet, D; Hippius, H; Itil, TM; Labhardt, F; Leeds, AA; Montanini, R; Morozov, G; Simon, P; Villeneuve, A | 1 |
| Boissier, JR; Janssen, PA; Julou, L; Loew, DM; Moller Nielsen, I; Munkvad, I; Randrup, A; Stille, G; Tedeschi, DH; Van Rossum, JM | 1 |
| Julou, L | 1 |
| Stille, G | 1 |
| Boissier, JR; Etevenon, PR; Gabilly, E; Simon, P | 1 |
| Janssen, PA | 1 |
| Boissier, JR; Giudicelli, JF; Simon, P | 1 |
| Morpurgo, C; Theobald, W | 1 |
| Ackermann, H; Eichenberger, E; Lauener, H; Stille, G | 1 |
4 review(s) available for apomorphine and Anochlesia
| Article | Year |
|---|---|
Sex differences in dopaminergic and cholinergic activity and function in the nigro-striatal system of the rat.
Topics: Acetylcholine; Animals; Apomorphine; Castration; Catalepsy; Corpus Striatum; Dopamine; Estradiol; Humans; Rats; Sex Characteristics; Stereotyped Behavior; Substantia Nigra | 1983 |
Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Corpus Striatum; Dopamine Agents; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1997 |
Catalepsy induced by body pinch: relation to stress-induced analgesia.
Topics: Analgesia; Animals; Apomorphine; Catalepsy; Endorphins; Haloperidol; Mice; Naloxone; Pain; Receptors, Dopamine; Stress, Physiological | 1986 |
[Compounds stimulating central catecholamine receptors].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Catecholamines; Clonidine; Dopamine; Extrapyramidal Tracts; Humans; Mice; Norepinephrine; Rats; Receptors, Adrenergic; Receptors, Drug; Stereotyped Behavior; Stimulation, Chemical | 1973 |
1 trial(s) available for apomorphine and Anochlesia
| Article | Year |
|---|---|
Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Basal Ganglia; Catalepsy; Dopamine; Haloperidol; Hippocampus; Locomotion; Male; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 1995 |
294 other study(ies) available for apomorphine and Anochlesia
| Article | Year |
|---|---|
Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adjuvants, Immunologic; Animals; Antioxidants; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Brain; Catalepsy; Catatonia; Dopamine; Haloperidol; Hypokinesia; Muscle Rigidity; Plant Bark; Rats; Reserpine; Tabebuia; Tremor; Water | 2022 |
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.
Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Enzyme Inhibitors; Haloperidol; Male; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar; Schizophrenia | 2021 |
An ethanolic extract of Desmodium adscendens exhibits antipsychotic-like activity in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Disease Models, Animal; Ethanol; Fabaceae; Female; Haloperidol; Mice; Mice, Inbred ICR; Motor Activity; Phytotherapy; Plant Extracts | 2017 |
Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis.
Topics: Animals; Antipsychotic Agents; Apomorphine; Asteraceae; Behavior, Animal; Catalepsy; Chlorpromazine; Disease Models, Animal; Haloperidol; Herb-Drug Interactions; Hypnotics and Sedatives; Mice, Inbred BALB C; Mice, Inbred ICR; Motor Activity; Phytotherapy; Plant Extracts; Psychotic Disorders | 2017 |
Morin Pretreatment Attenuates Schizophrenia-Like Behaviors in Experimental Animal Models.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonoids; Immobility Response, Tonic; Ketamine; Locomotion; Male; Mice; Rotarod Performance Test; Stereotyped Behavior | 2018 |
PT-31, a putative α2-adrenoceptor agonist, is effective in schizophrenia cognitive symptoms in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Cognition; Disease Models, Animal; Dopamine Agonists; Imidazolidines; Male; Memory; Memory Disorders; Memory, Long-Term; Mice; Mice, Inbred Strains; Rats; Rats, Wistar; Receptors, Adrenergic; Schizophrenia; Schizophrenic Psychology | 2019 |
Early life stress causes refractoriness to haloperidol-induced catalepsy.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Catecholamines; Cerebral Cortex; Dopamine Agonists; Female; Globus Pallidus; Haloperidol; Male; Maternal Exposure; Maternal-Fetal Relations; Pregnancy; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Receptors, Dopamine; Stress, Physiological; Subthalamic Nucleus; Ventral Thalamic Nuclei | 2013 |
Lunasin-induced behavioural effects in mice: focus on the dopaminergic system.
Topics: Amphetamine; Animals; Apomorphine; Bicuculline; Brain; Catalepsy; Central Nervous System Agents; Cyclic AMP; Dopamine Agents; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; HEK293 Cells; Humans; Ketamine; Male; Mice, Inbred C57BL; Motor Activity; Receptors, Dopamine D1; Receptors, Dopamine D2; Seizures; Soybean Proteins | 2013 |
Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Adrenergic Agents; Animals; Antiparkinson Agents; Apomorphine; Catalepsy; Cysteine Proteinase Inhibitors; Dopamine Agonists; Dose-Response Relationship, Drug; Functional Laterality; Levodopa; Male; Oxidopamine; Rats; Rats, Wistar; Reaction Time; Serotonin; Substantia Nigra | 2014 |
Evaluation of the antipsychotic potential of aqueous fraction of Securinega virosa root bark extract in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Euphorbiaceae; Female; Grooming; Haloperidol; Male; Medicine, African Traditional; Methanol; Mice; Phytotherapy; Plant Bark; Plant Extracts; Plant Roots; Solvents; Stereotyped Behavior; Swimming; Water | 2014 |
Effects of dehydroepiandrosterone in amphetamine-induced schizophrenia models in mice.
Topics: Adjuvants, Immunologic; Amphetamine; Animals; Apomorphine; Catalepsy; Central Nervous System Stimulants; Dehydroepiandrosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Locomotion; Mice; Schizophrenia; Statistics, Nonparametric; Time Factors | 2014 |
Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Chemistry, Pharmaceutical; Drug Compounding; Drug Delivery Systems; Mice; Micelles; Paliperidone Palmitate; Particle Size; Polyethylene Glycols; Psychotic Disorders; Vitamin E | 2016 |
Further evaluation of the tropane analogs of haloperidol.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Mice; Molecular Structure; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Structure-Activity Relationship; Tropanes | 2014 |
Atypical antipsychotic properties of AD-6048, a primary metabolite of blonanserin.
Topics: Animals; Antipsychotic Agents; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; Catalepsy; Corpus Striatum; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Injections, Subcutaneous; Male; Mice; Nucleus Accumbens; Oncogene Proteins v-fos; Piperazines; Piperidines; Pyridines | 2015 |
Antipsychotic-like effects of zolpidem in Wistar rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Diazepam; Dose-Response Relationship, Drug; Male; Motor Activity; Prepulse Inhibition; Pyridines; Rats; Rats, Wistar; Reflex, Startle; Risperidone; Zolpidem | 2016 |
EFFECTS OF VERAPAMIL ON DOPAMINE DEPENDENT BEHAVIOURS IN RATS.
Topics: Animals; Apomorphine; Avoidance Learning; Catalepsy; Dopamine; Haloperidol; Male; Rats; Receptors, Dopamine D2; Verapamil | 1999 |
Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized cata
Topics: Analysis of Variance; Animals; Apomorphine; Catalepsy; Conditioning, Classical; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Rats, Wistar | 2016 |
Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
Topics: Allosteric Regulation; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Brain; Catalepsy; Disease Models, Animal; Dopamine Agonists; Forelimb; Glutamic Acid; Haloperidol; HEK293 Cells; Humans; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Transfection | 2016 |
WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Azepines; Catalepsy; Clozapine; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Haloperidol; Indoles; Male; Mice; Rats; Rats, Sprague-Dawley; Reflex, Startle; Serotonin 5-HT2 Receptor Agonists; Stereotyped Behavior | 2009 |
Study of bipathic effect of haloperidol.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Stereotyped Behavior; Trihexyphenidyl | 2008 |
Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity.
Topics: Animals; Antipsychotic Agents; Anxiety; Apomorphine; Avoidance Learning; Body Temperature; Brain; Catalepsy; Dizocilpine Maleate; Dopamine; Glutamic Acid; Hyperkinesis; Male; Motor Activity; Peptaibols; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Rotarod Performance Test; Social Behavior | 2009 |
PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Drug Compounding; Lactic Acid; Mice; Microscopy, Atomic Force; Movement; Nanoparticles; Nervous System; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Solutions; Treatment Outcome | 2009 |
Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Cognition; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neostriatum; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Reverse Transcriptase Polymerase Chain Reaction; Schizophrenic Psychology; Social Behavior; Stereotyped Behavior | 2009 |
Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice.
Topics: Alpinia; Animals; Antipsychotic Agents; Anxiety; Apomorphine; Behavior, Animal; Catalepsy; Central Nervous System; Central Nervous System Depressants; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Maze Learning; Mice; Motor Activity; Oils, Volatile; Plant Extracts; Tail | 2009 |
Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
Topics: Allosteric Regulation; Animals; Apomorphine; Benzhydryl Compounds; Catalepsy; Disease Models, Animal; Haloperidol; Male; Mice; Mice, Knockout; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Reaction Time; Receptors, Metabotropic Glutamate; Stereotyped Behavior | 2010 |
Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Aphakia; Apomorphine; Behavior, Animal; Catalepsy; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Homeodomain Proteins; Mice; Mice, Knockout; Motor Activity; Neurons; Time Factors; Transcription Factors | 2010 |
Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Apomorphine; Body Temperature; Catalepsy; Cell Line; Central Nervous System Stimulants; CHO Cells; Cricetinae; Cricetulus; Dibenzothiepins; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Norepinephrine; Psychoses, Substance-Induced; Reserpine; Swimming | 2010 |
Prenatal lipopolysaccharide reduces motor activity after an immune challenge in adult male offspring.
Topics: Animals; Apomorphine; Brain; Catalepsy; Dopamine; Dopamine Agonists; Dopamine Antagonists; Exploratory Behavior; Female; Fetal Development; Haloperidol; Lipopolysaccharides; Locomotion; Male; Motor Activity; Neostriatum; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reflex; Sex Factors; Statistics, Nonparametric; Stereotyped Behavior | 2010 |
Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.
Topics: Animals; Apomorphine; Aripiprazole; Buffers; Catalepsy; Cell Membrane; Cerebral Cortex; Corpus Striatum; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Antagonism; Drug Partial Agonism; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Hippocampus; Male; Piperazines; Piperidines; Pyridines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Stereotyped Behavior; Up-Regulation | 2011 |
Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
Topics: Animals; Antipsychotic Agents; Apomorphine; Arginine; Catalepsy; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flavonoids; Indazoles; Male; Mice; Motor Activity; Nitric Oxide; Phytotherapy; Plant Leaves; Plant Preparations; Protein Kinase C; Psychotic Disorders; Rats; Rats, Wistar; Stereotyped Behavior; Syzygium; Tamoxifen | 2011 |
Effects of sertraline on experimental mouse models of psychosis.
Topics: Animals; Antidepressive Agents; Apomorphine; Catalepsy; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Mice; Motor Activity; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2012 |
Reversal of oxidative stress by histamine H₃ receptor-ligands in experimental models of schizophrenia.
Topics: Amphetamine; Animals; Antioxidants; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain Chemistry; Catalase; Catalepsy; Central Nervous System Stimulants; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Glutathione; Haloperidol; Histamine H3 Antagonists; Male; Mice; Motor Activity; Oxidative Stress; Rats; Schizophrenia; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2012 |
Sedative, antiepileptic and antipsychotic effects of Viscum album L. (Loranthaceae) in mice and rats.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Apomorphine; Catalepsy; Disease Models, Animal; Epilepsy; Female; Haloperidol; Hypnotics and Sedatives; Isoniazid; Male; Mice; Motor Activity; Phytotherapy; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Sleep; Viscum album | 2012 |
Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Brain; Catalepsy; Cells, Cultured; CHO Cells; Cricetinae; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Ligands; Locomotion; Male; Olanzapine; Piperidines; Prolactin; Pyridazines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D2; Schizophrenia; Serotonin | 2012 |
Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Asteraceae; Behavior, Animal; Body Temperature; Brain; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Agents; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Medicine, African Traditional; Mice; Mice, Inbred Strains; Motor Activity; Pentobarbital; Phytotherapy; Plant Extracts; Plant Leaves; Psychotic Disorders; Rats, Sprague-Dawley; Receptors, GABA-A; Sleep; Valproic Acid | 2012 |
Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.
Topics: 5-alpha Reductase Inhibitors; Animals; Apomorphine; Benzazepines; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Finasteride; Haloperidol; Male; Mice; Mice, Inbred C57BL; Motor Activity; Quinpirole; Sensory Gating; Stereotyped Behavior | 2013 |
New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophrenia.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Barbiturates; Catalepsy; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Hypothermia; Ketamine; Male; Mice; Motor Activity; Piperazines; Psychoacoustics; Reflex, Startle; Schizophrenia; Sleep | 2013 |
[On filo- and ontogenetic development of dopaminergic regylation of wakefulness-sleep cycle in vertabrates].
Topics: Animals; Apomorphine; Benzazepines; Brain Mapping; Catalepsy; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Haloperidol; Humans; Rana temporaria; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sleep; Vertebrates; Wakefulness | 2012 |
Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Female; Haloperidol; Male; Mice; Nootropic Agents; Phenazocine; Piperazines; Pyridines; Pyrrolidines; Rats; Receptors, sigma; Serotonin Antagonists; Sigma-1 Receptor; Sulpiride; Tartrates | 2002 |
Axonal degeneration and progressive neurologic disability in multiple sclerosis.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Binding, Competitive; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neurotoxins; Receptors, Dopamine D1; Spiperone; Tetrahydroisoquinolines | 2003 |
High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task.
Topics: Adrenergic Agents; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Catalepsy; Choice Behavior; Cognition; Conditioning, Operant; Electric Stimulation Therapy; Functional Laterality; Haloperidol; Male; Models, Animal; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Long-Evans; Reaction Time; Subthalamic Nucleus | 2003 |
IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Drug Hypersensitivity; Drug Tolerance; Epinephrine; Injections, Subcutaneous; Norepinephrine; Pharmacology; Rats; Research; Selective Serotonin Reuptake Inhibitors; Serotonin; Shock, Traumatic; Toxicology; Tranquilizing Agents | 1965 |
The acute EPS of haloperidol may be unrelated to its metabolic transformation to BCPP+.
Topics: Acetyl-CoA Carboxylase; Animals; Antipsychotic Agents; Apomorphine; Basal Ganglia Diseases; Carrier Proteins; Catalepsy; Dopamine Agonists; Fatty Acid Synthase, Type II; Haloperidol; Humans; Male; Mice; Psychomotor Performance; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior | 2003 |
Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Mice; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Serotonin Receptor Agonists; Stereotyped Behavior | 2006 |
In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Topics: 5-Hydroxytryptophan; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Avoidance Learning; Binding, Competitive; Catalepsy; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Head Movements; Hypothermia; Jaw; Male; Mice; Motor Activity; Piperazines; Pyridazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Tremor | 2006 |
Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Histamine Agonists; Histamine Antagonists; Methylhistamines; Mice; Models, Animal; Motor Activity; Piperidines; Receptors, Histamine H3; Schizophrenia; Stereotyped Behavior; Time Factors | 2006 |
In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Binding, Competitive; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Mice; Neostriatum; Olfactory Bulb; Receptors, Dopamine D2; Serotonin Receptor Agonists | 2006 |
WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Azepines; Catalepsy; Dizocilpine Maleate; Indoles; Male; Mice; Mice, Inbred DBA; Microdialysis; Motor Activity; Rats; Rats, Sprague-Dawley; Reflex, Startle; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Stereotyped Behavior; Substantia Nigra; Ventral Tegmental Area | 2007 |
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
Topics: Animals; Apomorphine; Benzoxazines; Cannabinoid Receptor Agonists; Catalepsy; Cyclohexanes; Cyclohexanols; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Morpholines; Naphthalenes; Phenols; Receptors, Cannabinoid; Sarcoma, Experimental | 2007 |
Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Binding, Competitive; Biological Availability; Brain; Catalepsy; Cognition; Humans; Indicators and Reagents; Male; Maze Learning; Memory Disorders; Quantitative Structure-Activity Relationship; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereotyped Behavior; Sulfonamides | 2007 |
Effects of dextromethorphan on dopamine dependent behaviours in rats.
Topics: Animals; Antitussive Agents; Apomorphine; Behavior, Animal; Catalepsy; Dextroamphetamine; Dextromethorphan; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Haloperidol; Male; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 2007 |
Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Brain; Catalepsy; Data Interpretation, Statistical; Dopamine Agonists; Hallucinogens; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Motor Activity; N-Methylaspartate; Piperazines; Postural Balance; Psychoses, Substance-Induced; Quinolones; Rats; Rats, Sprague-Dawley; Reflex, Startle; Serotonin Receptor Agonists | 2008 |
Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Excitatory Amino Acid Antagonists; Haloperidol; Ketamine; Locomotion; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior | 2008 |
Central effects of angiotensin II, its fragment and analogues.
Topics: Angiotensin II; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Catecholamines; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mice; Motor Activity; Rats; Seizures; Serotonin; Sleep; Stereotyped Behavior | 1984 |
Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
Topics: Animals; Apomorphine; Blepharoptosis; Catalepsy; Ceruletide; Clonidine; Drug Antagonism; Haloperidol; Humans; Hypnotics and Sedatives; Male; Mice; Motor Activity; Sincalide; Yohimbine | 1984 |
Preliminary observations regarding the cataleptogenic activity of ethosuximide in the mouse.
Topics: Animals; Apomorphine; Atropine; Catalepsy; Dose-Response Relationship, Drug; Ethosuximide; Humans; Male; Mice; Stereotyped Behavior | 1980 |
Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptors.
Topics: Animals; Apomorphine; Catalepsy; Drug Synergism; Female; Haloperidol; Humans; Mixed Function Oxygenases; Pimozide; Rats; Receptors, Dopamine; Receptors, Neurotransmitter; Tyrosine 3-Monooxygenase; Visual Cortex | 1980 |
[The neuroleptic efficiency of some butyrophenone and fluorinated phenothiazine derivatives (author's transl)].
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Haloperidol; Humans; Phenothiazines; Rats | 1980 |
Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
Topics: Animals; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Humans; Levodopa; Lysergic Acid Diethylamide; Male; MSH Release-Inhibiting Hormone; Naloxone; Parasympathomimetics; Rats; Synaptic Transmission; Time Factors | 1980 |
beta-Phenylethylamine reversal of chlorpromazine-induced activation of striatal tyrosine hydroxylase and catalepsy.
Topics: Animals; Apomorphine; Catalepsy; Caudate Nucleus; Chlorpromazine; Dextroamphetamine; Humans; Male; Phenethylamines; Rats; Tyrosine 3-Monooxygenase | 1981 |
Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings.
Topics: Animals; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Humans; Kinetics; Male; MSH Release-Inhibiting Hormone; Rats; Receptors, Dopamine; Receptors, Opioid; Spiperone | 1981 |
Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Butyrophenones; Catalepsy; Dogs; Humans; Male; Mescaline; Methamphetamine; Mice; Motor Activity; Rats; Stereotyped Behavior | 1981 |
[Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
Topics: Adenylyl Cyclases; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Brain; Catalepsy; Cats; Conditioning, Classical; Disease Models, Animal; Dogs; Dopamine; Dopamine Antagonists; Humans; In Vitro Techniques; Rats; Receptors, Dopamine; Vomiting | 1981 |
Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
Topics: Amphetamine; Analgesics; Analgesics, Opioid; Animals; Apomorphine; Catalepsy; Codeine; Dopamine; Drug Interactions; Fentanyl; Humans; Male; Morphine; Rats; Rats, Inbred Strains; Time Factors | 1981 |
Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
Topics: alpha-Methyltyrosine; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Clozapine; Haloperidol; Humans; Male; Methyltyrosines; Mice; Morphine; Motor Activity; Piperazines; Pyrimidines; Rats; Rats, Inbred Strains; Thioridazine | 1981 |
Behavioral pharmacologic studies in the monkey with DD-3480.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Butyrophenones; Catalepsy; Haloperidol; Humans; Macaca fascicularis; Macaca mulatta; Receptors, Dopamine; Stereotyped Behavior | 1982 |
Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Catalepsy; Chemical Phenomena; Chemistry; Humans; Lethal Dose 50; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1982 |
Behavioral pharmacology of the benzamides as compared to standard neuroleptics.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Catalepsy; Humans; Male; Metoclopramide; Mice; Oxotremorine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Sulpiride | 1982 |
Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Cholecystokinin; Extinction, Psychological; Female; Haloperidol; Humans; Hypnotics and Sedatives; Peptide Fragments; Rats; Rats, Inbred Strains; Sincalide; Stereotyped Behavior; Tetragastrin | 1982 |
Pharmacological effects of Ro 22-1319: a new antipsychotic agent.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Autonomic Nervous System; Avoidance Learning; Catalepsy; Dogs; Dopamine; Drug Interactions; Female; Hemodynamics; Humans; Isoquinolines; Male; Motor Activity; Neurons; Rats; Saimiri; Stereotyped Behavior | 1983 |
Enhanced effect of haloperidol and apomorphine after hypophysectomy: pharmacokinetic considerations.
Topics: Animals; Apomorphine; Brain; Catalepsy; Haloperidol; Humans; Hypophysectomy; Kinetics; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1983 |
Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Male; Quinolines; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Time Factors | 1983 |
Neuropharmacological profile of MD 790501, a new benzamide derivative.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Central Nervous System; Dogs; Drug Interactions; Dyskinesia, Drug-Induced; Female; Humans; Macaca mulatta; Male; Mice; Motor Activity; Norepinephrine; Nortropanes; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1983 |
Involvement of histaminergic mechanisms in the cataleptogenic effect of clonidine in mice.
Topics: Animals; Apomorphine; Catalepsy; Clonidine; Dose-Response Relationship, Drug; Drug Interactions; Histamine; Histidine; Humans; Mice; Phenoxybenzamine; Stereotyped Behavior; Yohimbine | 1983 |
Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Apomorphine; Buspirone; Catalepsy; Corpus Striatum; Dopamine; Female; Humans; Pyrimidines; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Synaptosomes; Tyrosine 3-Monooxygenase | 1983 |
Studies on the mechanism of action of substituted benzamide drugs.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Brain; Catalepsy; Corpus Striatum; Humans; Hyperkinesis; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra; Sulpiride; Tritium | 1984 |
Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Binding, Competitive; Brain Chemistry; Catalepsy; Chlorpromazine; Dogs; Female; Haloperidol; Histocytochemistry; Humans; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Spiperone; Sulpiride; Thioridazine; Vomiting | 1984 |
Psychopharmacological investigation of the monoamine oxidase inhibitory activity of molindone, a dihydroindolone neuroleptic.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Blepharoptosis; Catalepsy; Fenclonine; Fenfluramine; Humans; Indoles; Levodopa; Male; Mice; Molindone; Monoamine Oxidase Inhibitors; p-Chloroamphetamine; Rats; Reserpine; Stereotyped Behavior; Tryptamines; Tryptophan | 1984 |
Dopamine involvement in ACTH-induced grooming behavior.
Topics: Adrenocorticotropic Hormone; Animals; Apomorphine; Behavior, Animal; Butaclamol; Catalepsy; Dopamine; Grooming; Humans; Injections, Intraventricular; Male; Metoclopramide; Mice; Pimozide | 1982 |
[Effect of an imidazobenzodiazepine (RO 15-1788) on aggressive behavior in mice].
Topics: Aggression; Animals; Apomorphine; Benzodiazepinones; Brain; Catalepsy; Dose-Response Relationship, Drug; Flumazenil; Haloperidol; Humans; Hydroxyindoleacetic Acid; Male; Mice; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin | 1984 |
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
Topics: Animals; Anticonvulsants; Apomorphine; Behavior, Animal; Catalepsy; Drug Interactions; gamma-Aminobutyric Acid; Humans; Kinetics; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Stereotyped Behavior | 1982 |
A biphasic influence of globus pallidus lesions: spontaneous catalepsy followed by anticataleptic effect.
Topics: Animals; Apomorphine; Catalepsy; Functional Laterality; Globus Pallidus; Humans; Kainic Acid; Male; Motor Activity; Muscle Tonus; Rats; Rats, Inbred Strains; Stereotaxic Techniques; Stereotyped Behavior; Time Factors | 1983 |
Cholinergic-dopaminergic interactions in experimental catalepsy.
Topics: Animals; Apomorphine; Catalepsy; Dopamine; Drug Interactions; Haloperidol; Humans; Male; Mice; Parasympathetic Nervous System; Parasympatholytics; Pilocarpine | 1983 |
Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.
Topics: Animals; Apomorphine; Catalepsy; Haloperidol; Humans; Male; Methamphetamine; Naloxone; Rats; Stereotyped Behavior | 1984 |
[Relevance of dopaminergic system to the catalepsy induced by tetrahydroberberine (author's transl)].
Topics: Animals; Apomorphine; Berberine; Berberine Alkaloids; Catalepsy; Female; Haloperidol; Humans; Male; Mice; Parasympathetic Nervous System; Rats; Receptors, Dopamine | 1981 |
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Body Weight; Catalepsy; Corpus Striatum; Flupenthixol; Humans; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereoisomerism; Stereotyped Behavior; Thioxanthenes | 1984 |
[Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
Topics: Animals; Apomorphine; Catalepsy; Corpus Striatum; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Haloperidol; Humans; Male; Mice; Receptors, Dopamine; Spiperone; Time Factors | 1984 |
The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent.
Topics: 5,8,11,14-Eicosatetraynoic Acid; 8,11,14-Eicosatrienoic Acid; Animals; Apomorphine; Aspirin; Catalepsy; Corpus Striatum; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fatty Acids, Unsaturated; Guinea Pigs; Haloperidol; Humans; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1984 |
Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Chemical Phenomena; Chemistry; Dopamine; Humans; Prolactin; Pyrrolidines; Rats; Receptors, Dopamine; Spiperone | 1984 |
Antidyskinetic properties of estrogens.
Topics: Animals; Apomorphine; Catalepsy; Estradiol; Estrogens; Glutamate Decarboxylase; Haloperidol; Humans; Male; Motor Activity; Movement Disorders; Rats; Rats, Inbred Strains | 1983 |
Effects of calcitonin on the brain of aged rats.
Topics: Age Factors; Animals; Apomorphine; Calcitonin; Catalepsy; Drug Synergism; Extrapyramidal Tracts; Haloperidol; Humans; Hyperkinesis; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains | 1983 |
Small doses of apomorphine induce catalepsy and antagonize methamphetamine stereotypy in rats.
Topics: Animals; Apomorphine; Catalepsy; Humans; Male; Methamphetamine; Molindone; Rats; Receptors, Dopamine; Stereotyped Behavior | 1982 |
Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride.
Topics: Adult; Animals; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Ergolines; Female; Haloperidol; Humans; Lisuride; Male; Mice; Motor Activity; Prolactin; Rats; Rats, Inbred Strains | 1983 |
Alterations in apomorphine concentration in spinal cord and brain follow the time course of catalepsies induced by different treatments.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; gamma-Aminobutyric Acid; Haloperidol; Humans; Picrotoxin; Rabbits; Spinal Cord; Stereotyped Behavior; Substantia Nigra; Time Factors | 1983 |
Biphasic effects of direct, but not indirect, GABA mimetics and antagonists on haloperidol-induced catalepsy.
Topics: Allylglycine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Drug Interactions; GABA Antagonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Male; Muscimol; Rats; Stereotyped Behavior | 1980 |
Reticuline: a dopamine receptor blocker.
Topics: Alkaloids; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzylisoquinolines; Catalepsy; Dopamine Antagonists; Haloperidol; Humans; Isoquinolines; Male; Mice; Rats | 1980 |
The development of catalepsy in drug-free mice on repeated testing.
Topics: Animals; Apomorphine; Atropine; Behavior, Animal; Catalepsy; Handling, Psychological; Humans; Male; Mice; Mice, Inbred Strains; Naloxone; Posture; Time Factors | 1980 |
Chronic administration of haloperidol during development: later psychopharmacological responses to apomorphine and arecoline.
Topics: Animals; Apomorphine; Arecoline; Behavior, Animal; Catalepsy; Female; Haloperidol; Humans; Male; Pregnancy; Rats; Receptors, Dopamine | 1980 |
Tonic immobility in domestic fowl: possible interaction of serotonergic and dopaminergic mechanisms.
Topics: Animals; Apomorphine; Catalepsy; Chickens; Fenfluramine; Haloperidol; Humans; Immobilization; Receptors, Dopamine; Receptors, Serotonin; Tryptophan | 1981 |
Postictal behavioral arrest in the rat: "catalepsy" or "catatonia"?
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Catatonia; Electric Stimulation; Female; Haloperidol; Humans; Naloxone; Rats; Seizures | 1981 |
Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
Topics: Animals; Apomorphine; Catalepsy; Corpus Striatum; Haloperidol; Humans; Injections; Kainic Acid; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Time Factors | 1982 |
N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Catalepsy; Dizocilpine Maleate; Haloperidol; Ketamine; Mice; Neuroprotective Agents; Parkinson Disease, Secondary; Perphenazine; Rats; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 1995 |
Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors.
Topics: Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Catalepsy; Dopamine Antagonists; Quinolines; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Stimulation, Chemical; Substantia Nigra | 1995 |
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Biogenic Monoamines; Brain; Catalepsy; Cattle; CHO Cells; Choroid Plexus; Cricetinae; Cyclic AMP; Dopamine Antagonists; Guinea Pigs; Humans; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Quipazine; Rats; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists; Swine; Thiazoles | 1995 |
Effect of manipulation of the GABA system on dopamine-related behaviors.
Topics: 3-Mercaptopropionic Acid; Animals; Apomorphine; Baclofen; Catalepsy; Dopamine Agonists; GABA Agents; Haloperidol; Male; Mice; Motor Activity; Picrotoxin; Rats; Rats, Wistar; Stereotyped Behavior | 1995 |
[Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Yawning | 1995 |
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Catalepsy; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Piperazines; Presynaptic Terminals; Quinolones; Radioligand Assay; Rats; Reserpine; Spiperone; Stereotyped Behavior; Synapses; Tritium | 1995 |
Behavioral and biochemical changes after bilateral electrolytic lesions of the red nucleus of rat.
Topics: Animals; Apomorphine; Azepines; Behavior, Animal; Body Temperature; Brain Chemistry; Catalepsy; Dopamine; Dopamine Agonists; Haloperidol; Male; Rats; Rats, Wistar; Red Nucleus; Serotonin; Spiperone; Stereotyped Behavior | 1995 |
Effects of atypical antipsychotic agents on social behavior in rodents.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Catalepsy; Chlorpromazine; Clozapine; Diazepam; Haloperidol; Isoxazoles; Male; Mice; Mice, Inbred Strains; Piperidines; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Social Behavior | 1993 |
The influence of antineoplaston A5 on the central dopaminergic structures.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Dopamine; Haloperidol; Male; Mice; Motor Activity; Norepinephrine; Penile Erection; Peptides; Rats; Rats, Wistar; Receptors, Dopamine; Stereotyped Behavior; Yawning | 1994 |
Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Memory; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Stereotyped Behavior | 1994 |
Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Basal Ganglia Diseases; Behavior, Animal; Catalepsy; Cats; Cebus; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Fixation, Ocular; Male; Mice; Motor Activity; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Saimiri; Stereotyped Behavior; Swimming | 1993 |
Effects of carbaryl on some dopaminergic behaviors in rats.
Topics: Administration, Oral; Animals; Apomorphine; Behavior, Animal; Carbaryl; Catalepsy; Cholinesterases; Dopamine; Haloperidol; Male; Rats; Rats, Wistar; Stereotyped Behavior; Yawning | 1994 |
Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agents; Drug Synergism; Haloperidol; Male; Methamphetamine; Motor Activity; Nicotine; Rats; Rats, Wistar; Stereotyped Behavior | 1993 |
Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
Topics: Animals; Animals, Newborn; Apomorphine; Basal Ganglia; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agents; Female; Haloperidol; Hippocampus; Motor Activity; Neurons, Afferent; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1993 |
Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding, Competitive; Catalepsy; Corpus Striatum; Cyclization; Dopamine D2 Receptor Antagonists; Frontal Lobe; Hippocampus; Indoles; Isoindoles; Male; Mice; Molecular Structure; Motor Activity; Phthalazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Thiazoles | 1994 |
Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Chloroquine; Drug Interactions; Female; Male; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine; Stereotyped Behavior | 1994 |
Injection of apomorphine into the medial prefrontal cortex of the rat increases haloperidol-induced catalepsy.
Topics: Animals; Apomorphine; Catalepsy; Dopamine; Haloperidol; Injections; Male; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 1994 |
Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Topics: 4-Butyrolactone; Adenylyl Cyclases; Amphetamine; Animals; Apomorphine; Biogenic Monoamines; Brain; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Locomotion; Male; Motor Activity; Perfusion; Potassium; Quinolines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Serotonin; Stereotyped Behavior; Synapses; Tetrahydronaphthalenes; Time Factors; Tritium | 1993 |
Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves.
Topics: Animals; Antidepressive Agents; Apomorphine; Blepharoptosis; Catalepsy; Central Nervous System; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Hypothermia, Induced; Imipramine; Male; Methamphetamine; Mianserin; Mice; Mice, Inbred Strains; Motor Activity; Oleanolic Acid; Phenobarbital; Plant Extracts; Reserpine; Sleep; Stereotyped Behavior; Swimming; Tetrabenazine; Triterpenes | 1993 |
Effects of remoxipride's metabolites on dopamine D2 receptors and receptor functions in the rat.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Hypothermia; In Vitro Techniques; Male; Motor Activity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride | 1993 |
Effects of a single administration of buspirone on catalepsy, yawning and stereotypy in rats.
Topics: Analysis of Variance; Animals; Apomorphine; Buspirone; Catalepsy; Haloperidol; Male; Rats; Rats, Wistar; Stereotyped Behavior; Yawning | 1993 |
Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy.
Topics: Aging; Animals; Apomorphine; Brain Chemistry; Catalepsy; Corpus Striatum; Dose-Response Relationship, Drug; Female; Haloperidol; Oxidopamine; Rats; Rats, Sprague-Dawley | 1993 |
D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Catalepsy; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Stereotyped Behavior; Up-Regulation | 1993 |
Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Avoidance Learning; Azepines; Catalepsy; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Indoles; Male; Mice; Motor Activity; Oxindoles; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior | 1996 |
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Brain; Catalepsy; Clozapine; Dopamine; Drug Design; Humans; Molecular Structure; Phosphatidylinositols; Piperazines; Prazosin; Rats; Receptors, Adrenergic; Receptors, Dopamine; Serotonin Antagonists; Thiazoles | 1996 |
7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Biological Availability; Catalepsy; Chromones; Male; Mice; Molecular Structure; Motor Activity; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Structure-Activity Relationship | 1996 |
Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Schizophrenia | 1996 |
SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Basal Ganglia Diseases; Catalepsy; Cattle; Dopamine Antagonists; Humans; In Vitro Techniques; Limbic System; Male; Mice; Motor Activity; Prolactin; Quinoxalines; Radioligand Assay; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Dopamine D1; Retina; Sympathectomy, Chemical | 1996 |
[The effect on central dopaminergic structures of various hydrazides of phosphorylated carbonic acids and diaziridines].
Topics: Acetates; Animals; Apomorphine; Body Temperature; Catalepsy; Dopamine Agents; Drug Interactions; Haloperidol; Hydrazines; Levodopa; Mice; Stereotyped Behavior | 1996 |
Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Topics: Animals; Apomorphine; Benzazepines; Catalepsy; Cholinergic Antagonists; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Mice; Mice, Inbred Strains; Parasympathetic Nervous System; Parasympathomimetics; Physostigmine; Pilocarpine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Muscarinic; Scopolamine | 1997 |
Central administration of FMRFamide produces antipsychotic-like effects in rodents.
Topics: 5-Hydroxytryptophan; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Conditioning, Operant; FMRFamide; Injections, Intraventricular; Male; Mice; Rats; Rats, Wistar; Stereotaxic Techniques | 1997 |
Behavioral activity of 1S,3R-ACPD, an agonist of metabotropic glutamate receptors.
Topics: Animals; Apomorphine; Avoidance Learning; Catalepsy; Cycloleucine; Haloperidol; Injections, Intraventricular; Male; Memory; Motor Activity; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Stereotyped Behavior | 1997 |
Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Rats; Rats, Sprague-Dawley | 1998 |
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Brain; Catalepsy; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine Antagonists; GABA Modulators; Male; Mice; Mice, Inbred ICR; Molecular Structure; Piperazines; Quinolones; Rats; Stereotyped Behavior; Structure-Activity Relationship | 1998 |
Antipsychotic-like profile of alstonine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Drug Evaluation, Preclinical; Haloperidol; Male; Mice; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Secologanin Tryptamine Alkaloids; Sleep; Stereotyped Behavior | 1998 |
D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Tolerance; Fluphenazine; Genetic Vectors; Grooming; Haloperidol; Male; Mice; Quinpirole; Receptors, Dopamine D2; RNA, Antisense; Stereotyped Behavior; Up-Regulation | 1998 |
[Effect of (+/-)12-chloroscoulerine on brain dopamine receptors].
Topics: Animals; Apomorphine; Berberine Alkaloids; Brain; Catalepsy; Cattle; Dopamine Antagonists; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Stereotyped Behavior | 1996 |
Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Locomotion; Male; Mice; Mice, Inbred BALB C; Motor Activity; Olanzapine; Pirenzepine; Stereotyped Behavior; Stereotypic Movement Disorder | 1999 |
Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan.
Topics: Angiotensin Receptor Antagonists; Animals; Apomorphine; Benzazepines; Catalepsy; Dopamine; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Losartan; Male; Mice; Mice, Inbred BALB C; Motor Activity; Perphenazine; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stereotyped Behavior | 1998 |
Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Free Radical Scavengers; Guinea Pigs; Haloperidol; Head Movements; Male; Mice; Phenazocine; Phencyclidine; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, sigma; Risperidone; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Sulpiride; Tartrates | 1999 |
Synthesis and preliminary pharmacological investigations of 1-(1,2-dihydro-2-acenaphthylenyl)piperazine derivatives as potential atypical antipsychotic agents in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding, Competitive; Brain Chemistry; Catalepsy; Chemical Phenomena; Chemistry, Physical; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Mice; Naphthalenes; Piperazines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Spiperone; Stereotyped Behavior | 1999 |
Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Discrimination, Psychological; Dopamine Agents; Dopamine Agonists; Exploratory Behavior; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Proline; Rats; Rats, Wistar; Stereotyped Behavior; Sulpiride; Tyrosine | 1999 |
Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
Topics: Animals; Apomorphine; Binding, Competitive; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Sulfur Radioisotopes; Tritium; Up-Regulation | 1999 |
Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
Topics: Animals; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Clozapine; Haloperidol; Injections, Intraperitoneal; Male; Mice; Motor Activity; Neurotensin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Time Factors | 2000 |
Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats.
Topics: Acoustic Stimulation; Amoxapine; Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Dyskinesia, Drug-Induced; Indophenol; Male; Proactive Inhibition; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2000 |
Effects of flunarizine on dopamine dependent behaviours in rats.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Calcium Channel Blockers; Catalepsy; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Flunarizine; Injections, Intraperitoneal; Male; Methamphetamine; Rats; Stereotyped Behavior | 1999 |
The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission.
Topics: Animals; Antidepressive Agents; Apomorphine; Carbamazepine; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Haloperidol; Male; Neurotransmitter Agents; Oxcarbazepine; Rats; Rats, Wistar; Receptors, Dopamine; Stereotypic Movement Disorder; Swimming | 2000 |
Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
Topics: Animals; Antiparkinson Agents; Apomorphine; Binding, Competitive; Brain Chemistry; Catalepsy; Dopamine; Dopamine Antagonists; Haloperidol; Homovanillic Acid; Isoquinolines; Male; Motor Activity; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Wistar; Tetrahydroisoquinolines; Tritium | 2000 |
Distinct functions of the two isoforms of dopamine D2 receptors.
Topics: Animals; Apomorphine; Benzazepines; Catalepsy; Chimera; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis; Protein Isoforms; Quinpirole; Receptors, Dopamine D2; Signal Transduction; Spiperone; Synapses | 2000 |
Fatty acid derivatives of clozapine: prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat.
Topics: Amides; Animals; Apomorphine; Arousal; Brain; Catalepsy; Clozapine; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Interactions; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine | 2001 |
Comparison of 12-chloroscoulerine enantiomers on animal behavior to dopamine receptors.
Topics: Animals; Apomorphine; Behavior, Animal; Berberine Alkaloids; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Male; Mice; Rats; Rats, Sprague-Dawley; Stereoisomerism; Stereotyped Behavior | 1999 |
Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Catalepsy; Central Nervous System; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Indoles; Injections, Intraventricular; Male; Morphine; Motor Activity; Narcotics; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Serotonin Antagonists; Serotonin Receptor Agonists; Stereotyped Behavior; Sulfonamides | 2002 |
Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Female; Male; Motor Activity; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Social Behavior | 2002 |
The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Conditioning, Psychological; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Gonadal Steroid Hormones; Male; Mice; Motor Activity; Pregnanolone; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, GABA-A | 2002 |
Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.
Topics: Animals; Antipsychotic Agents; Apomorphine; Atropine; Benztropine; Catalepsy; Drug Interactions; Haloperidol; Humans; Male; Morphine; Rats; Scopolamine; Time Factors | 1976 |
Synthesis and pharmacological properties of a series of antidopaminergic piperidyl benzamides.
Topics: Animals; Apomorphine; Benzamides; Catalepsy; Depression, Chemical; Dextroamphetamine; Dopamine; Female; Humans; Male; Metoclopramide; Mice; Piperidines; Rats; Stereotyped Behavior; Structure-Activity Relationship | 1977 |
Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Analgesics, Opioid; Animals; Apomorphine; Catalepsy; Caudate Nucleus; Dextroamphetamine; Dopamine; Drug Interactions; Globus Pallidus; Humans; In Vitro Techniques; Injections; Mice; Morphine; Motor Activity; Olfactory Bulb; Rats; Stimulation, Chemical; Substantia Nigra | 1977 |
A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Benzamides; Binding, Competitive; Catalepsy; Corpus Striatum; Female; Haloperidol; Humans; In Vitro Techniques; Male; Mice; Rats; Receptors, Dopamine; Stereotyped Behavior | 1978 |
Dopamine antagonistic effects of a series of analogues of oxiperomide and spiroxatrine measured behaviourally in the rodent.
Topics: Animals; Apomorphine; Behavior, Animal; Benzimidazoles; Catalepsy; Dioxanes; Dopamine Antagonists; Drug Interactions; Guinea Pigs; Humans; Male; Rats; Spiro Compounds; Stereotyped Behavior | 1978 |
Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Butanones; Catalepsy; Humans; Lethal Dose 50; Male; Methamphetamine; Mice; Motor Activity; Rats; Stereotyped Behavior; Structure-Activity Relationship | 1978 |
Synthesis of 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole derivatives and their central nervous system activities.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Humans; Indoles; Male; Methamphetamine; Mice; Motor Activity; Muscle Relaxation; Rats; Self Stimulation; Stereoisomerism; Stereotyped Behavior; Structure-Activity Relationship | 1979 |
Predictability and specificity of behavioral screening tests for neuroleptics.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Drug Evaluation, Preclinical; Humans; Male; Mice; Motor Activity; Rats; Stereotyped Behavior | 1979 |
Pharmacological and biochemical studies on a new potential neuroleptic, N-(1-benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-08050).
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Catalepsy; Chlorpromazine; Dogs; Dopamine; Drug Interactions; Female; Haloperidol; Humans; Male; Methamphetamine; Mice; Physostigmine; Rats; Stereotyped Behavior; Synaptic Membranes | 1979 |
Differential antagonism of antiavoidance, cataleptic and ptotic effects of neuroleptics by biperiden.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Biperiden; Blepharoptosis; Catalepsy; Dopamine Antagonists; Drug Interactions; Humans; Male; Mice; Norepinephrine; Oxotremorine; Piperidines | 1979 |
Is morphine-induced catalepsy related to activation of dopaminergic neurones?
Topics: Animals; Apomorphine; Catalepsy; Dopamine; Haloperidol; Humans; Male; Methyltyrosines; Morphine; Naloxone; Neurons; Rats; Stereotyped Behavior | 1978 |
A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
Topics: Aggression; Amphetamine; Analgesics, Opioid; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Dexetimide; Dextromoramide; Dogs; Dopamine; Drug Combinations; Haloperidol; Humans; Meperidine; Methadone; Mice; Morphine; Phenoperidine; Pimozide; Rats; Receptors, Drug; Stereotyped Behavior; Substance Withdrawal Syndrome; Tranquilizing Agents; Vomiting | 1975 |
Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.
Topics: 5,7-Dihydroxytryptamine; Animals; Apomorphine; Behavior, Animal; Brain Injuries; Catalepsy; Ergolines; Female; Haloperidol; Humans; Hydroxydopamines; Lysergic Acid Diethylamide; Male; Medial Forebrain Bundle; Neural Pathways; Prochlorperazine; Rats; Rotation; Urea | 1978 |
Evidence for increased apomorphine-sensitive dopaminergic effects after acute treatment with morphine.
Topics: Animals; Apomorphine; Catalepsy; Dopamine; Drug Interactions; Humans; Male; Metergoline; Morphine; Motor Activity; Rats; Stereotyped Behavior; Time Factors | 1977 |
Beta-endorphin induced akinesia in rats: effect of apomorhine and alpha-methyl-p-tyrosine and related modifications of dopamine turnover in the basal ganglia.
Topics: Animals; Apomorphine; Basal Ganglia; Brain; Catalepsy; Cornea; Dopamine; Drug Interactions; Endorphins; Humans; Injections, Intraventricular; Male; Methyltyrosines; Norepinephrine; Peptides; Rats; Reflex; Serotonin | 1977 |
The interaction of clonidine with dopamine-dependent behaviour in rodents.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Clonidine; Corpus Striatum; Dextroamphetamine; Dopamine; Drug Interactions; Haloperidol; Humans; Limbic System; Male; Mice; Motor Activity; Norepinephrine; Rats; Reserpine; Serotonin; Stereotyped Behavior | 1977 |
Substituted benzamides as cerebral dopamine antagonists in rodents.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Behavior, Animal; Benzamides; Brain; Catalepsy; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Male; Metoclopramide; Mice; Receptors, Dopamine; Sulpiride | 1977 |
The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
Topics: Animals; Apomorphine; Brain; Catalepsy; Chlorpromazine; Dibenzocycloheptenes; Dopamine; Haloperidol; Humans; Male; Mice; Piribedil; Quinolizines; Receptors, Dopamine; Receptors, Drug; Spiperone; Structure-Activity Relationship; Tranquilizing Agents | 1977 |
Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Brain Chemistry; Brain Stem; Catalepsy; Cerebellum; Cerebral Ventricles; Dopamine; Female; Haloperidol; Humans; Hydroxydopamines; Male; Norepinephrine; Rats; Serotonin; Stereotyped Behavior | 1977 |
Dopamine receptor blocking activity of sulpiride in the central nervous system.
Topics: Administration, Oral; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Cerebral Ventricles; Chlorpromazine; Compulsive Behavior; Haloperidol; Humans; Injections, Intravenous; Male; Methamphetamine; Rats; Receptors, Dopamine; Sulpiride | 1977 |
Dopaminergic mediation of beta-endorphin-induced catalepsy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain Chemistry; Catalepsy; Corpus Striatum; Dopamine; Drug Synergism; Endorphins; Haloperidol; Humans; Male; Naloxone; Rats | 1978 |
[Effect of phosphodiesterase inhibitors on neuroleptic-induced catalepsy and apomorphine-induced stereotypic movements in rats].
Topics: Animals; Apomorphine; Atropine; Catalepsy; Haloperidol; Humans; Movement Disorders; Papaverine; Phosphodiesterase Inhibitors; Rats | 1978 |
Differential behavioral activities from anterior and posterior hypothalamic lesions in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Humans; Hydroxydopamines; Hypothalamus; Hypothalamus, Anterior; Hypothalamus, Posterior; Male; Motor Activity; Rats; Receptors, Dopamine; Stereotyped Behavior | 1978 |
Evidence that a nigral gabaergic--cholinergic balance controls posture.
Topics: Animals; Apomorphine; Arecoline; Behavior, Animal; Carbachol; Catalepsy; Choline O-Acetyltransferase; gamma-Aminobutyric Acid; Haloperidol; Humans; Kainic Acid; Male; Posture; Rats; Receptors, Cholinergic; Receptors, Muscarinic; Scopolamine; Stereotyped Behavior; Substantia Nigra | 1979 |
[Cocaine-induced reverse tolerance phenomenon and electrical kindling (author's transl)].
Topics: Amygdala; Animals; Apomorphine; Catalepsy; Cats; Cocaine; Drug Tolerance; Electric Stimulation; Electroencephalography; Humans; Receptors, Dopamine; Seizures | 1978 |
[Pharmacological studies of long-acting phenothiazines with particular reference to fluphenazine decanoate (author's transl)].
Topics: Animals; Apomorphine; Blood Pressure; Body Temperature; Brain; Catalepsy; Catecholamines; Electrocardiography; Fluphenazine; Guinea Pigs; Humans; In Vitro Techniques; Injections, Subcutaneous; Locomotion; Male; Methamphetamine; Mice; Rats; Time Factors | 1978 |
Altered response to apomorphine and haloperidol after nine days of cocaine injections.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Cocaine; Drug Interactions; Haloperidol; Humans; Male; Rats; Stereotyped Behavior; Time Factors | 1979 |
Presynaptic subsensitivity as a possible basis for sensitization by long-term dopamine mimetics.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine; Humans; Male; Protein Binding; Radioligand Assay; Rats; Synapses | 1979 |
Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
Topics: Animals; Apomorphine; Binding, Competitive; Brain; Butyrophenones; Catalepsy; Haloperidol; Humans; Male; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Sulpiride | 1979 |
Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine.
Topics: Animals; Apomorphine; Brain; Catalepsy; Dextroamphetamine; Dopamine; Drug Interactions; Haloperidol; Humans; Hydroxyindoleacetic Acid; Male; Probenecid; Rats; Serotonin | 1979 |
[Relationship of the homovanillic acid content in the rat brain after the administration of a neuroleptic and the degree of dopamine receptor sensitivity to an agonist].
Topics: Animals; Apomorphine; Brain; Catalepsy; Haloperidol; Homovanillic Acid; Humans; Male; Phenylacetates; Rats; Receptors, Dopamine; Stereotyped Behavior; Time Factors | 1979 |
Serotonin--dopamine interactions in the nigrostriatal system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Catalepsy; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Homovanillic Acid; Humans; Male; Rats; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Substantia Nigra | 1979 |
Effect of haloperidol on reflex activation of rat alpha-motoneurones. A possible explanation for akinesia and catalepsy?
Topics: Animals; Apomorphine; Catalepsy; Haloperidol; Humans; In Vitro Techniques; Male; Motor Neurons; Movement Disorders; Rats; Reflex; Time Factors | 1979 |
Accumulation of apomorphine in caudate nucleus and hippocampus of the rabbit.
Topics: Animals; Apomorphine; Catalepsy; Caudate Nucleus; Cerebellum; Dose-Response Relationship, Drug; Haloperidol; Hippocampus; Humans; Rabbits; Receptors, Dopamine; Stereotyped Behavior | 1979 |
Pharmacology of cis(Z)-clopenthixol decanoate, a depot neuroleptic.
Topics: Administration, Oral; Animals; Apomorphine; Barbiturates; Behavior, Animal; Catalepsy; Clopenthixol; Delayed-Action Preparations; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Escape Reaction; Female; Humans; Injections, Subcutaneous; Male; Mice; Motor Activity; Rats; Thioxanthenes; Time Factors | 1977 |
The pharmacology of a new potent, long acting neuroleptic, piflutixol.
Topics: Adenylyl Cyclases; Amphetamine; Anesthesia; Animals; Apomorphine; Arousal; Barbiturates; Behavior, Animal; Catalepsy; Dogs; Dopamine Antagonists; Escape Reaction; Ethanol; Female; Humans; Male; Methylphenidate; Mice; Motor Activity; Piperidines; Rabbits; Rats; Thioxanthenes; Tranquilizing Agents | 1977 |
[Pharmacological studies of an antipschotic agent, penfluridol. (1). The central pharmacological actions].
Topics: Agonistic Behavior; Animals; Apomorphine; Avoidance Learning; Blepharoptosis; Body Temperature; Catalepsy; Cats; Central Nervous System; Chlorpromazine; Conditioning, Classical; Cooperative Behavior; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Haloperidol; Haplorhini; Hexobarbital; Humans; Locomotion; Male; Methamphetamine; Mice; Parasympatholytics; Penfluridol; Piperidines; Rats | 1976 |
Dopaminergic function in two patients with catalepsy.
Topics: Adult; Amobarbital; Apomorphine; Catalepsy; Female; Growth Hormone; Humans; Injections, Intravenous; Injections, Subcutaneous; Receptors, Dopamine; Schizophrenia; Sodium Chloride | 1977 |
[Behavioral pharmacology of a new antidepressant, lopramine].
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Avoidance Learning; Blepharoptosis; Body Temperature; Catalepsy; Dibenzazepines; Drug Synergism; Emotions; Humans; Imipramine; Lethal Dose 50; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Muscle Relaxation; Oxotremorine; Physostigmine; Rats; Stereotyped Behavior | 1976 |
Papaverine, drug-induced stereotypy and catalepsy and biogenic amines in the brain of the rat.
Topics: Animals; Apomorphine; Behavior; Biogenic Amines; Brain; Brain Chemistry; Catalepsy; Dopamine; Haloperidol; Humans; Hydroxyindoleacetic Acid; Male; Norepinephrine; Papaverine; Rats; Serotonin; Stereotyped Behavior | 1976 |
[Behavioral pharmacology of berberine-type alkaloids. (2) Central depressant effects of tetrahydroberberine (THB) and related compounds].
Topics: Animals; Anticonvulsants; Apomorphine; Avoidance Learning; Barbiturates; Behavior, Animal; Berberine; Berberine Alkaloids; Body Temperature; Catalepsy; Cooperative Behavior; Drug Synergism; Electroencephalography; Female; Hemodynamics; Humans; Locomotion; Male; Mescaline; Methamphetamine; Mice; Rats; Sleep; Tranquilizing Agents | 1976 |
The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Chlorpromazine; Dextroamphetamine; Dibenzocycloheptenes; Discrimination Learning; Dogs; Epinephrine; Fluphenazine; Humans; Male; Mice; Motor Activity; Quinolizines; Rats; Stereotyped Behavior; Tranquilizing Agents; Vomiting | 1975 |
Behavioural supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine.
Topics: Apomorphine; Brain Chemistry; Catalepsy; Dopamine; Humans; Hydroxydopamines; Injections, Intraventricular; Motor Activity; Norepinephrine; Pimozide; Receptors, Drug; Stimulation, Chemical; Sympathectomy | 1975 |
Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Clozapine; Dextroamphetamine; Dibenzazepines; Dose-Response Relationship, Drug; Drug Synergism; Fluphenazine; Haloperidol; Humans; Isoquinolines; Male; Methyltyrosines; Pimozide; Rats; Spiro Compounds; Stereotyped Behavior; Succinimides; Sulpiride; Thioridazine; Tranquilizing Agents | 1975 |
Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
Topics: Animals; Apomorphine; Body Temperature; Brain; Catalepsy; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Metoclopramide; Norepinephrine; Phenylacetates; Rats; Stimulation, Chemical; Time Factors | 1975 |
[Behavior pharmacology of maprotiline, a new antidepressant].
Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Escape Reaction; Eyelids; Haloperidol; Humans; Imipramine; Levodopa; Maprotiline; Methamphetamine; Mice; Motor Activity; Oxotremorine; Physostigmine; Rats; Reserpine; Sleep; Tetrabenazine | 1975 |
Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Benzimidazoles; Blepharoptosis; Body Temperature Regulation; Body Weight; Catalepsy; Dextroamphetamine; Dogs; Escape Reaction; Female; Guinea Pigs; Haloperidol; Humans; Lethal Dose 50; Male; Mice; Norepinephrine; Penfluridol; Pimozide; Piperidines; Rats; Self Stimulation; Stereotyped Behavior; Tranquilizing Agents | 1975 |
The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Benzodiazepines; Catalepsy; Conflict, Psychological; Discrimination Learning; Female; Male; Mice; Olanzapine; Pirenzepine; Rats; Rats, Inbred Strains | 1992 |
Effects of calcitonin gene-related peptide on extrapyramidal motor system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior, Animal; Calcitonin Gene-Related Peptide; Catalepsy; Corpus Striatum; Dopamine; Extrapyramidal Tracts; Injections, Intraventricular; Male; Motor Activity; Rats; Rats, Sprague-Dawley | 1992 |
Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents.
Topics: Amides; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Imides; Male; Mice; Molecular Structure; Motor Activity; Phthalimides; Piperazines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Self Stimulation; Social Behavior; Spiro Compounds; Stereotyped Behavior; Thiazoles | 1991 |
Effects of cannabidiol in animal models predictive of antipsychotic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Blepharoptosis; Cannabidiol; Catalepsy; Male; Models, Psychological; Prolactin; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1991 |
An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia.
Topics: Age Factors; Animals; Apomorphine; Catalepsy; Estradiol; Female; Haloperidol; Male; Rats; Receptors, Dopamine; Schizophrenia; Sex Factors; Testosterone | 1991 |
[Comparison of central stimulating effects between ephedrine and apomorphine].
Topics: Animals; Apomorphine; Blepharoptosis; Catalepsy; Ephedrine; Haloperidol; Male; Mice; Motor Activity; Prazosin; Rats; Rats, Inbred Strains; Stereotyped Behavior; Sulpiride; Vomiting | 1991 |
Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Catalepsy; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Ketamine; Male; Methyltyrosines; Motor Activity; Rats; Stereotyped Behavior | 1991 |
Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Dopamine; Dopamine Agents; Ergolines; Female; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
Dopaminergic drugs influence the intensity of catalepsy induced by microinjections of carbachol into the reticular formation.
Topics: Animals; Apomorphine; Brain Stem; Carbachol; Catalepsy; Dopamine Agents; Haloperidol; Injections; Injections, Subcutaneous; Levodopa; Male; Microinjections; Motor Activity; Rats; Rats, Inbred Strains; Reticular Formation; Stereotyped Behavior | 1990 |
The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice.
Topics: Animals; Apomorphine; Catalepsy; Cerebral Cortex; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Motor Activity; Reference Values | 1991 |
Influences of diterpene sclareol glycol on some dopamine related behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Diterpenes; Dopamine; Haloperidol; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior | 1991 |
Neuropharmacological actions of the superactive agonist analog D-TRP-6-LH-RH after peripheral injection into mice.
Topics: Analgesia; Animals; Apomorphine; Behavior, Animal; Catalepsy; Central Nervous System; Exploratory Behavior; Gonadotropin-Releasing Hormone; Male; Mice; Pain Measurement; Picrotoxin; Seizures; Stereotyped Behavior; Triptorelin Pamoate | 1990 |
Effects of yohimbine on dopamine dependent behaviours in rats and mice.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Dopamine; Haloperidol; Male; Methamphetamine; Mice; Psychomotor Performance; Rats; Stereotyped Behavior; Yohimbine | 1990 |
Effects of a Palicourea marcgravii leaf extract on some dopamine-related behaviors of rats.
Topics: Animals; Apomorphine; Catalepsy; Drug Synergism; Haloperidol; Male; Motor Activity; Plant Extracts; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1990 |
Is experimental catalepsy properly measured?
Topics: Adrenal Glands; Animals; Apomorphine; Catalepsy; Disease Models, Animal; Drug Interactions; Haloperidol; Male; Rats; Rats, Inbred Strains | 1990 |
Effects of dihydroergotoxine on some dopamine-related behaviors in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Catalepsy; Catecholamines; Dihydroergotoxine; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1990 |
A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Binding, Competitive; Catalepsy; Dihydroxyphenylalanine; Haloperidol; Injections, Subcutaneous; Iodine Radioisotopes; Male; Motor Activity; Papaverine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Tetrahydroisoquinolines | 1989 |
Significance of the cerebral dopaminergic neurotransmission for the individual differences in learning and memory (experiments on rats).
Topics: Animals; Apomorphine; Catalepsy; Dopamine; Ergolines; Haloperidol; Learning; Male; Memory; Rats; Rats, Inbred Strains; Reinforcement, Psychology; Stereotyped Behavior; Synaptic Transmission | 1989 |
Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system.
Topics: Aggression; Animals; Antipsychotic Agents; Apomorphine; Body Temperature; Catalepsy; Cats; Clonidine; Dogs; Female; Macaca fascicularis; Male; Mice; Motor Activity; Piperazines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Stereotyped Behavior; Vomiting | 1989 |
5-Piperazinylalkyl-2(3H)-oxazolones with neuroleptic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Dogs; Indicators and Reagents; Male; Mice; Molecular Structure; Motor Activity; Muscles; Oxazoles; Oxazolone; Piperazines; Rats; Stereotyped Behavior; Structure-Activity Relationship | 1989 |
Dopamine autoreceptor agonists attenuate spontaneous motor activity but not spontaneous fighting in individually-housed mice.
Topics: Aggression; Agonistic Behavior; Animals; Apomorphine; Catalepsy; Dopamine Agents; Dose-Response Relationship, Drug; Housing, Animal; Male; Mice; Motor Activity; Piperidines; Social Isolation; Stereoisomerism | 1989 |
[Neuroleptic properties of Y-20024, a new benzofurancarboxamide derivative].
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzofurans; Body Temperature; Catalepsy; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Male; Methamphetamine; Mice; Motor Activity; Prolactin; Pyrrolidines; Rats; Rats, Inbred Strains; Self Stimulation | 1989 |
Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
Topics: Animals; Apomorphine; Barbiturates; Catalepsy; Haloperidol; Male; Pentobarbital; Phenytoin; Rats; Receptors, Dopamine; Stereotyped Behavior; Synaptic Transmission | 1988 |
[Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Catalepsy; Chemical Phenomena; Chemistry; Dopamine; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Stereotyped Behavior | 1985 |
Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Male; Mice; Molindone; Receptors, Dopamine; Receptors, Dopamine D2; Time Factors | 1985 |
Synthesis and neuroleptic activity of a series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzim idazolone derivatives.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzimidazoles; Brain; Catalepsy; Cattle; Chemical Phenomena; Chemistry; Male; Mice; Piperidines; Rats; Receptors, Dopamine; Spiperone; Structure-Activity Relationship | 1987 |
The effect of neurotransmitters on cataleptic behavior induced by PG D2 in rats.
Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Catalepsy; Dopamine; Fenclonine; Injections, Intraventricular; Levodopa; Male; Motor Activity; Neurotransmitter Agents; Norepinephrine; Prostaglandin D2; Prostaglandins D; Rats; Rats, Inbred Strains; Serotonin; Time Factors | 1987 |
Atypical antipsychotic agents: patterns of activity in a series of 3-substituted 2-pyridinyl-1-piperazine derivatives.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dioxanes; Electrophysiology; Haplorhini; Piperazines; Rats; Spiro Compounds; Stereotyped Behavior; Structure-Activity Relationship | 1988 |
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Benzazepines; Catalepsy; Dogs; Dopamine; Dopamine Antagonists; Homovanillic Acid; Male; Mice; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Stereotyped Behavior; Vomiting | 1988 |
Antipsychotic properties of new N-(4-substituted-1-piperazinylethyl)- and N-(4-substituted-1-piperidinylethyl)-phthalimides.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Chemical Phenomena; Chemistry; Female; Guinea Pigs; Lethal Dose 50; Male; Mice; Motor Activity; Parasympatholytics; Pergolide; Phthalimides; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1988 |
Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Catalepsy; Ergolines; Hydroxydopamines; Ketanserin; Male; Motor Activity; Oxidopamine; Pergolide; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Stereotyped Behavior | 1985 |
The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine; Emetics; Male; Motor Activity; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior | 1986 |
Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Male; Motor Activity; Rats; Stereoisomerism; Stereotyped Behavior | 1986 |
BRL 20596, a novel anilide with central dopamine antagonist activity.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Antagonists; Drug Synergism; Electroencephalography; Hemodynamics; Hexobarbital; Homovanillic Acid; Isonipecotic Acids; Male; Mice; Motor Activity; Prolactin; Rats; Rats, Inbred Strains; Spiperone; Stereotyped Behavior | 1986 |
Preliminary phytochemical, pharmacological and antibacterial studies of the alkaloidal extracts of the leaves of Synclisia scabrida Miers.
Topics: Alkaloids; Animals; Apomorphine; Behavior, Animal; Catalepsy; Chickens; Chromatography, Thin Layer; Electroencephalography; Electromyography; Female; Male; Plant Extracts; Plants, Medicinal; Pseudomonas aeruginosa; Psychotic Disorders; Rats; Rats, Inbred Strains; Staphylococcus aureus | 1986 |
The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide.
Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Apomorphine; Avoidance Learning; Benzamides; Brain; Brain Chemistry; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Catalepsy; Dogs; Dopamine Antagonists; Electroencephalography; Exploratory Behavior; Male; Mice; Motor Activity; Prolactin; Rats; Social Behavior | 1988 |
Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist.
Topics: Animals; Apomorphine; Benzazepines; Binding, Competitive; Catalepsy; Corpus Striatum; Dose-Response Relationship, Drug; Ergolines; Humans; Male; Motor Activity; Pergolide; Phenethylamines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereoisomerism | 1985 |
D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Catalepsy; Male; Mice; Molindone; Motor Activity; Receptors, Dopamine | 1988 |
Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Catalepsy; Conditioning, Psychological; Dopamine; Droperidol; Drug Tolerance; Haloperidol; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1988 |
Comparative studies on the central effects of the angiotensin II analogue (Sar1 azaVal3 Ile8) AT II.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Animals; Apomorphine; Biogenic Amines; Brain; Catalepsy; Conflict, Psychological; Male; Mice; Pentylenetetrazole; Rats; Saralasin; Seizures; Stereotyped Behavior | 1988 |
[Anti-dopaminergic activity of pyrrolidinyl-benzamide derivatives].
Topics: Animals; Apomorphine; Avoidance Learning; Benzamides; Catalepsy; Conditioning, Psychological; Male; Mice; Pyrrolidines; Rats; Rats, Inbred Strains; Stereotyped Behavior; Structure-Activity Relationship | 1987 |
Dopamine dependent behaviours in rats with bilateral ibotenic acid-induced lesions of the globus pallidus.
Topics: Amphetamines; Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine; Functional Laterality; Globus Pallidus; Haloperidol; Ibotenic Acid; Locomotion; Male; Oxazoles; Rats; Rats, Inbred Strains; Stereotaxic Techniques; Stereotyped Behavior | 1986 |
Lack of the effect of ketamine on some dopaminergic behaviors in rats.
Topics: Animals; Apomorphine; Catalepsy; Haloperidol; Ketamine; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning | 1986 |
[Effect of 3 new GABA-ergics on reserpine catalepsy and apomorphine sedation in rats].
Topics: Animals; Apomorphine; Catalepsy; Drug Synergism; gamma-Aminobutyric Acid; Male; Psychotropic Drugs; Rats; Rats, Inbred Strains; Reserpine | 1987 |
Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
Topics: Anesthesia, General; Animals; Apomorphine; Catalepsy; Corpus Striatum; Dopamine; Gallamine Triethiodide; Haloperidol; Halothane; Male; Rats; Rats, Inbred Strains; Restraint, Physical; Stereotyped Behavior | 1986 |
Differential changes in dopaminergic receptor sensitivity induced by agonist drugs.
Topics: Animals; Apomorphine; Benserazide; Brain Chemistry; Catalepsy; Drug Therapy, Combination; Haloperidol; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1985 |
Effect of cyclic nucleotides on apomorphine stereotypy and chlorpromazine catalepsy in mice.
Topics: Animals; Apomorphine; Catalepsy; Chlorpromazine; Male; Mice; Mice, Inbred Strains; Morphine; Nucleotides, Cyclic; Stereotyped Behavior; Structure-Activity Relationship | 1985 |
Experimental catalepsy is both enhanced and disrupted by apomorphine.
Topics: Animals; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Motor Activity; Pilocarpine; Receptors, Dopamine; Time Factors | 1985 |
Antidopaminergic effects of bisbenzyl and benzyl tetrahydroisoquinoline alkaloids.
Topics: Alkaloids; Animals; Apomorphine; Behavior, Animal; Benzylisoquinolines; Binding, Competitive; Catalepsy; Corpus Striatum; Hydroxydopamines; Isoquinolines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation; Spiperone; Stereotyped Behavior; Tetrahydroisoquinolines | 1985 |
[2 new GABA-ergics (GABA-linoleamide and GABA-steatamide). On 2 experimental models of depression].
Topics: Animals; Apomorphine; Catalepsy; Depressive Disorder; Drug Synergism; gamma-Aminobutyric Acid; Humans; Male; Psychotropic Drugs; Rats; Reserpine | 1985 |
[Adaptation to neuroleptic preparations and several ways of combatting it (experimental study)].
Topics: Animals; Apomorphine; Catalepsy; Drug Therapy, Combination; Drug Tolerance; Haloperidol; Male; Mice; Schizophrenia, Paranoid; Trifluoperazine | 1985 |
Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice.
Topics: Animals; Apomorphine; Catalepsy; Chlorpromazine; Domperidone; Drug Interactions; Haloperidol; Injections, Intraventricular; Mice; Spiperone; Stereotyped Behavior; Sulpiride | 1985 |
Possible dissociation of central dopamine receptor antagonism and cataleptic behavior.
Topics: Animals; Apomorphine; Catalepsy; Haloperidol; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Time Factors | 1985 |
[Metabolism of dopamine and norepinephrine in rat brain after acute and chronic administration of haloperidol, loxapine and clozapine].
Topics: Animals; Apomorphine; Azepines; Brain; Catalepsy; Chlorides; Corpus Striatum; Dopamine; Drug Evaluation, Preclinical; Drug Tolerance; Haloperidol; Homovanillic Acid; Humans; Norepinephrine; Phenylacetates; Piperazines; Polycyclic Compounds; Rats; Tranquilizing Agents | 1974 |
A study of the role of catecholamines in the response to various central stimulants.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Catecholamines; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Drug Interactions; Ephedrine; Female; Humans; Methamphetamine; Methylphenidate; Methyltyrosines; Motor Activity; Phenmetrazine; Rats; Reserpine; Stereotyped Behavior | 1973 |
Pharmacological study of pipotiazine (19.366 R.P.) and its undecylenic (19.551 R.P.) and palmitic (19.552 R.P.) esters.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dogs; Esters; Fluphenazine; Guinea Pigs; Humans; Lethal Dose 50; Mice; Motor Activity; Palmitic Acids; Phenothiazines; Piperidines; Rats; Respiration; Sleep; Species Specificity; Sulfonamides; Time Factors; Undecylenic Acids | 1973 |
Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromine; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Ergot Alkaloids; Humans; Hydroxydopamines; Mice; Rats; Reserpine; Stereotyped Behavior; Substantia Nigra; Time Factors | 1974 |
The role of dopamine in pilocarpine-induced catalepsy.
Topics: Animals; Apomorphine; Atropine; Behavior, Animal; Body Temperature; Brain Chemistry; Catalepsy; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Homovanillic Acid; Humans; Male; Methyltyrosines; Pilocarpine; Rats; Time Factors | 1974 |
Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.
Topics: Animals; Apomorphine; Axons; Benzimidazoles; Body Weight; Brain; Brain Injuries; Brain Mapping; Catalepsy; Cerebral Ventricles; Dopamine; Feeding and Eating Disorders; Humans; Hypothalamus; Male; Mental Disorders; Microscopy, Fluorescence; Nerve Degeneration; Posture; Rats; Stereotaxic Techniques; Stimulation, Chemical; Substantia Nigra; Synaptic Transmission; Thirst | 1971 |
Psychopharmacological effects of thiothixene and related compounds.
Topics: Animals; Apomorphine; Avoidance Learning; Body Temperature; Catalepsy; Chlorpromazine; Dextroamphetamine; Discrimination, Psychological; Dogs; Drug Synergism; Ethanol; Hexobarbital; Humans; Male; Mice; Mortality; Phenothiazines; Prochlorperazine; Psychopharmacology; Rats; Reflex; Tranquilizing Agents; Tremor | 1968 |
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzimidazoles; Blepharoptosis; Body Temperature Regulation; Cardiovascular System; Catalepsy; Cats; Chlorpromazine; Delayed-Action Preparations; Dogs; Female; Guinea Pigs; Haloperidol; Haplorhini; Histamine H1 Antagonists; Humans; In Vitro Techniques; Male; Methods; Mice; Muscle Contraction; Norepinephrine; Psychotic Disorders; Rabbits; Rats; Swine; Tranquilizing Agents; Vasoconstrictor Agents | 1968 |
[Pharmacological studies on the effect of neuroleptics in animals after single and repeated application].
Topics: Amphetamine; Animals; Apomorphine; Body Temperature; Catalepsy; Cats; Chlorpromazine; Conditioning, Classical; Cricetinae; Female; Humans; Male; Mice; Nictitating Membrane; Phenothiazines; Rats; Thioridazine; Tremorine | 1968 |
Influences of cholinergic mechanisms on the function and turnover of brain dopamine.
Topics: Animals; Apomorphine; Atropine; Basal Ganglia; Brain; Catalepsy; Cyclopentanes; Dopamine; Hallucinogens; Haloperidol; Humans; Mandelic Acids; Norepinephrine; Parasympatholytics; Piperidines; Rats; Scopolamine; Trihexyphenidyl | 1971 |
Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Blepharoptosis; Body Weight; Bromine; Butyrophenones; Catalepsy; Dogs; Dose-Response Relationship, Drug; Electroshock; Feeding Behavior; Female; Food Deprivation; Haloperidol; Humans; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Norepinephrine; Rats; Time Factors | 1974 |
Synthesis and preliminary pharmacology of a novel butyrophenone derivative, ID-4708.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Butyrophenones; Catalepsy; Cats; Chlorpromazine; Drug Evaluation, Preclinical; Drug Synergism; Electroencephalography; Epinephrine; Haloperidol; Hexobarbital; Humans; Hydrocarbons, Fluorinated; Imipramine; Lethal Dose 50; Male; Methamphetamine; Mice; Motor Activity; Pain; Piperidines; Rats; Trifluperidol | 1974 |
[Effect of neuroleptic agents in the chronic pharmacological experiment].
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Corpus Striatum; Dibenzoxazepines; Drug Tolerance; Electroencephalography; Fluphenazine; Haloperidol; Homovanillic Acid; Humans; Piperazines; Rats; Sleep; Tranquilizing Agents | 1974 |
Evidence that methadone blocks dopamine receptors in the brain.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Basal Ganglia; Brain; Brain Chemistry; Butyrophenones; Catalepsy; Dopamine; Humans; Hydroxyindoleacetic Acid; Hypothermia; Methadone; Norepinephrine; Phenothiazines; Phenylacetates; Rats; Sensory Receptor Cells; Tritium; Tyrosine | 1972 |
Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
Topics: Animals; Apomorphine; Brain Chemistry; Catalepsy; Catechols; Caudate Nucleus; Chlorpromazine; Clonidine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Fluorometry; Homovanillic Acid; Humans; Male; Methyltyrosines; Mice; Morphine; Motor Activity; Rats; Serine; Species Specificity; Stereotaxic Techniques; Thiocarbamates | 1974 |
Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats.
Topics: Alkaloids; Animals; Apomorphine; Aporphines; Behavior, Animal; Brain Chemistry; Catalepsy; Dimethyl Sulfoxide; Dopamine; Emetine; Humans; Hydroxyindoleacetic Acid; Isoquinolines; Male; Phenylacetates; Rats; Reserpine | 1972 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain Chemistry; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Hydroxydopamines; Methylphenidate; Methyltyrosines; Rats; Reserpine; Scopolamine | 1973 |
Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
Topics: Animals; Apomorphine; Basal Ganglia; Catalepsy; Corpus Striatum; Dibenzoxazepines; Dopamine; Drug Tolerance; Haloperidol; Homovanillic Acid; Humans; Male; Piperazines; Rats; Stereotyped Behavior; Time Factors; Tranquilizing Agents | 1973 |
Drug-induced catalepsy as influenced by psychostimulants, apomorphine, L-dopa, and yohimbine.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Dihydroxyphenylalanine; Hallucinogens; Haloperidol; Humans; Male; Mecamylamine; Mice; Mice, Inbred Strains; Nicotine; Paraoxon; Pempidine; Phenmetrazine; Pilocarpine; Sparteine; Tetrabenazine; Trifluoperazine; Yohimbine | 1973 |
[L-DOPA jumping test in mice: its use in the study of antagonistic psychotropic drugs].
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Dihydroxyphenylalanine; Drug Evaluation, Preclinical; Humans; Mice; Tranquilizing Agents | 1973 |
Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Body Temperature; Brain Chemistry; Catalepsy; Depression, Chemical; Desipramine; Dextroamphetamine; Dihydroxyphenylalanine; Disulfides; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Exploratory Behavior; Humans; Hydrazines; Hypnotics and Sedatives; Male; Methyltyrosines; Motor Activity; Norepinephrine; Posture; Rats; Receptors, Drug; Scopolamine; Time Factors | 1973 |
Pharmacology of neuroleptics upon repeated administration.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Catalepsy; Cross Reactions; Dose-Response Relationship, Drug; Drug Tolerance; Ethanol; Fluphenazine; Germ-Free Life; Haloperidol; Humans; Male; Methylphenidate; Mice; Mice, Inbred Strains; Pimozide; Piperazines; Stereotyped Behavior; Thioxanthenes; Time Factors; Tranquilizing Agents | 1974 |
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
Topics: Amantadine; Animals; Apomorphine; Blood Pressure; Body Temperature; Brain Chemistry; Catalepsy; Chlorpromazine; Dextroamphetamine; Disulfides; Dopamine; Female; Fluphenazine; Haloperidol; Humans; Imidazoles; Male; Methyltyrosines; Motor Activity; Norepinephrine; Oxotremorine; Parasympatholytics; Rats; Reflex; Reserpine; Spiro Compounds; Stereotyped Behavior | 1974 |
Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
Topics: Amphetamine; Animals; Apomorphine; Aporphines; Catalepsy; Dextroamphetamine; Dopamine; Haloperidol; Humans; Locomotion; Male; Methyltyrosines; Mice; Norepinephrine; Rats; Receptors, Drug; Time Factors | 1974 |
[Behavioral effects of lithium chloride].
Topics: Aggression; Analysis of Variance; Anesthesia; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Chlorpromazine; Drug Synergism; Electroshock; Emotions; Escape Reaction; Ethanol; Exploratory Behavior; Humans; Lithium; Locomotion; Male; Mescaline; Methamphetamine; Mice; Rats; Seizures; Sleep; Thiopental; Vocalization, Animal | 1974 |
Methods for evaluation of long acting neuroleptic drugs in animals.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Biological Assay; Catalepsy; Conditioning, Psychological; Delayed-Action Preparations; Dogs; Evaluation Studies as Topic; Humans; Methods; Rats; Tranquilizing Agents; Vomiting | 1972 |
Morphine catalepsy in the rat: relation to striatal dopamine metabolism.
Topics: Animals; Apomorphine; Brain Chemistry; Catalepsy; Chlorpromazine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Male; Methadone; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Rats; Rats, Inbred Strains | 1972 |
Effects of apomorphine and amphetamine in rats with a permanent catalepsy induced by diencephalic lesion.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Diencephalon; Humans; Male; Rats; Time Factors | 1971 |
[8-Chloro-10-(4-methylpiperazino)dibenzo(b,f)thiepin and analogues: new highly active neuroleptics].
Topics: Animals; Apomorphine; Catalepsy; Dibenzothiepins; Humans; Locomotion; Mice; Piperazines; Rats; Tranquilizing Agents | 1969 |
4'-Fluoro-4-(1,4,5,6-tetrahydroazepinol[4,5-b]indol-3(2H)-yl)butyrophenones.
Topics: Amphetamine; Animals; Apomorphine; Azepines; Blepharoptosis; Body Temperature; Butyrophenones; Catalepsy; Central Nervous System; Chemical Phenomena; Chemistry; Depression, Chemical; Drug Antagonism; Drug Synergism; Ethanol; Humans; Indoles; Male; Mice; Pentobarbital; Rats | 1970 |
Definition and classification of neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Autonomic Nervous System; Basal Ganglia Diseases; Behavior; Catalepsy; Chemical Phenomena; Chemistry; Humans; Hypnotics and Sedatives; Motor Activity; Parkinson Disease, Secondary; Psychotic Disorders; Structure-Activity Relationship; Tranquilizing Agents | 1970 |
The neuroleptics. 3. Pharmacology. Introduction.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior; Behavior, Animal; Blepharoptosis; Brain; Catalepsy; Chemical Phenomena; Chemistry; Conditioning, Psychological; Disease Models, Animal; Dopamine Antagonists; Humans; Psychotic Disorders; Self Stimulation; Tranquilizing Agents | 1970 |
On the interaction between neuroleptics and antiparkinson drugs.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; Catalepsy; Dogs; Drug Interactions; Humans; Rats; Reserpine; Tranquilizing Agents | 1970 |
Neurophysiological substrates of the pharmacological criteria for neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Caudate Nucleus; Corpus Striatum; Cortical Spreading Depression; Depression, Chemical; Electrophysiology; Humans; Rats; Species Specificity; Tranquilizing Agents | 1970 |
Antagonism by apomorphine of the permanent catalepsy induced by bilateral diencephalic lesions in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Diencephalon; Electroencephalography; Humans; Male; Rats; Rats, Inbred Strains; Sensory Receptor Cells; Time Factors | 1970 |
Chemical and pharmacological classification of neuroleptics.
Topics: Amphetamine; Aniline Compounds; Animals; Apomorphine; Behavior, Animal; Blepharoptosis; Butylamines; Catalepsy; Chemical Phenomena; Chemistry; Conditioning, Operant; Dogs; Humans; Intestinal Absorption; Molecular Conformation; Norepinephrine; Propylamines; Rats; Self Stimulation; Time Factors; Tranquilizing Agents | 1970 |
[Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
Topics: Animals; Apomorphine; Blepharoptosis; Bretylium Compounds; Catalepsy; Central Nervous System; Chlorpromazine; Dextroamphetamine; Dibenzylchlorethamine; Ergotamine; Eyelids; Guanethidine; Humans; Methyldopa; Mice; Phenoxybenzamine; Phentolamine; Propranolol; Rats; Tranquilizing Agents; Yohimbine | 1968 |
Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature; Catalepsy; Chlorpromazine; Dextroamphetamine; Dogs; Humans; Mastication; Mice; Movement; Pentobarbital; Perphenazine; Rats; Scopolamine; Trifluoperazine; Trihexyphenidyl; Vomiting | 1964 |
The pharmacological properties of a potent neurotropic compound from the dibenzothiazepine group.
Topics: Acetylcholine; Animals; Apomorphine; Behavior, Animal; Blood Circulation; Blood Pressure; Body Temperature; Catalepsy; Cats; Chlorpromazine; Electroencephalography; Electromyography; Electroshock; Guinea Pigs; Histamine; Humans; In Vitro Techniques; Locomotion; Rabbits; Rats; Serotonin; Tranquilizing Agents | 1965 |